Podcasts about patients

Links & Mentions: Consult booking link: www.dryazdancoaching.com/consult Email me: DrDYazdan@gmail.com Make more money video: www.dryazdancoaching.com/MDM Follow me for more tips: (@DrYazdan) www.instagram.com/dryazdan and (@DrYazdanCoaching) www.Instagram.com/dryazdancoaching Episode Summary: Today's episode dives into a topic every dentist experiences but almost none talk about: The subtle energetic frequency of your practice—and how it shapes patient trust, case acceptance, team culture, and overall production. If you've ever wondered why two practices with the same skills, same equipment, and same procedures get wildly different patient reactions… this episode is your answer. ✨ What We Cover in This Episode 1. The Energy Patients Feel Before You Say a Word Patients are scanning your practice for safety the moment they walk in—long before they hear your clinical recommendations. 2. The Energetic Imprint of Your Physical Space Your office communicates through: • Lighting • Colors • Sounds • Smells • Organization • Team dynamics You'll learn why outdated doesn't mean untrustworthy—intentionality matters far more than renovations. 3. Your Team as Your Energetic Extension Patients don't know who's responsible for what—they just feel the collective vibe. We discuss: • How a stressed or disengaged team member silently undermines trust • Why team energy always mirrors the doctor • What your leadership tone creates (or destroys) 4. The Power of Your Presence Patients decide whether to trust you within 7 seconds. You'll learn how your internal state—your mental narrative, your confidence, your clarity—communicates louder than your words. Plus: a powerful real-life story of a frustrated patient whose entire experience changed through a single shift in energy. 5. Upgrading Your Energetic Frequency as the Doctor Practical steps you can implement today 6. Why Feelings—Not Procedures—Create Loyalty Patients don't remember every word you say. They remember how they felt in your presence. This episode connects patient experience to real human emotion—family, connection, safety—and how this shapes retention and referrals.

Dr. Andy Southerland and Dr. Dipika Aggarwal discuss her remarkable journey as both a physician and a patient. After overcoming stage four colon cancer, she experienced a life‑altering stroke that reshaped her perspective.  Show transcript: Dr. Andy Southerland: Hello everyone. This is Andy Southerland and for this week's Neurology Minute, I've just been speaking with our colleague, Dipika Aggarwal, who's a clinical assistant professor of neurology at University of Kansas, who's been sharing her story for the Physician's Patient series from Cancer Survivorship and as a stroke survivor. And for the Neurology Minute, we wanted to share an important pearl that Dipika shared with me in her interview about stroke recovery and specifically about mental health outcomes after stroke. So Dipika, please, share with us for the Neurology Minute. Dr. Dipika Aggarwal: So yes, my biggest takeaway point from my own stroke experience was the neuropsychiatric complications that can happen as a risk from stroke. The most important ones being post-stroke depression, post-stroke anxiety. Even if the literature says that they can happen just for 30% of the cases, in reality, I think the incidence is more. But then they can affect quality of life of the stroke survivor, the recovery, and even in some cases can affect their mortality. So I think it is really important for healthcare providers, especially the neurologists, to ask their patients how they are doing mentally or emotionally. I think it is as important as checking their vitals during every visit. It is as important as that, because again, it can affect their recovery. Dr. Andy Southerland: Well, thank you, Dipika. I think it's a good message for all of us in the busyness of our clinics and seeing patients in rapid throughput in and out of the hospital with stroke to make sure that not only in those early days, but also all the way out in the continuum of their recovery, to continue to come back to their mental health recovery. And their personal recovery, as you've articulated, which is so critical to one stroke recovery. And for this and more, I really encourage our listeners, please listen to the entirety of this interview. You will come away with it being a better neurologist for your patients. I promise you that. And I'm truly grateful again to Dipika for joining us for this week's Neurology Minute.

CardioNerds (Dr. Shazli Khan, Dr. Jenna Skowronski, and Dr. Shiva Patlolla) discuss the management of patients post‑heart transplantation with Dr. Shelley Hall from Baylor University Medical Center and Dr. MaryJane Farr from UTSW. In this comprehensive review, we cover the physiology of the transplanted heart, immunosuppression strategies, rejection surveillance, and long-term complications including cardiac allograft vasculopathy (CAV) and malignancy. Audio editing for this episode was performed by CardioNerds intern Dr. Bhavya Shah. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. CardioNerds Heart Success Series PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls The Denervated Heart: The donor heart is surgically severed from the autonomic nervous system, leading to a higher resting heart rate (90-110 bpm) due to loss of vagal tone. Because the heart relies on circulating catecholamines rather than neural input to increase heart rate, patients experience a delayed chronotropic response to exercise and stress. Importantly, because afferent pain fibers are severed, ischemia is often painless. Rejection Surveillance: Rejection is classified into Acute Cellular Rejection (ACR), which is T-cell mediated, and Antibody-Mediated Rejection (AMR), which is B-cell mediated. While endomyocardial biopsy remains the gold standard for diagnosis, non-invasive surveillance using gene-expression profiling (e.g., AlloMap) and donor-derived cell-free DNA (dd-cfDNA) is increasingly utilized to reduce the burden of invasive procedures. The Infection Timeline: The risk of infection follows a predictable timeline based on the intensity of immunosuppression. The first month is dominated by nosocomial infections. Months one through six are the peak for opportunistic infections (Cytomegalovirus, Pneumocystis, Toxoplasmosis) requiring prophylaxis. After six months, patients are primarily at risk for community-acquired pathogens, though late viral reactivation can occur. Cardiac Allograft Vasculopathy (CAV): Unlike native coronary artery disease, CAV presents as diffuse, concentric intimal thickening that affects the entire length of the vessel, including the microvasculature. Due to denervation, patients rarely present with angina; instead, CAV manifests as unexplained heart failure, fatigue, or sudden cardiac death. Malignancy Risk: Long-term immunosuppression significantly increases the risk of malignancy. Skin cancers (squamous and basal cell) are the most common, followed by Post-Transplant Lymphoproliferative Disorder (PTLD), which is often driven by Epstein-Barr Virus (EBV) reactivation. Notes Notes: Notes drafted by Dr. Patlolla 1. What are the unique physiological features of the transplanted heart? The hallmark of the transplanted heart is denervation. Because the autonomic nerve fibers are severed during harvest, the heart loses parasympathetic or vagal tone, resulting in a resting tachycardia (typically 90-110 bpm). The heart also loses the ability to mount a reflex tachycardia; thus, the heart rate response to exercise or hypovolemia relies on circulating catecholamines, which results in a slower “warm-up” and “cool-down” period during exertion. 2. What are the pillars of maintenance immunosuppression regimen? The triple drug maintenance regimen typically consists of: Calcineurin Inhibitor (CNI): Tacrolimus is preferred over cyclosporine. Key side effects include nephrotoxicity, hypertension, tremor, hyperkalemia, and hypomagnesemia. Antimetabolite: Mycophenolate mofetil (MMF) inhibits lymphocyte proliferation. Key side effects include leukopenia and GI distress. Corticosteroids: Prednisone is used for maintenance but is often weaned to low doses or discontinued after the first year to mitigate metabolic side effects (diabetes, osteoporosis, weight gain). 3. How is rejection classified and diagnosed? Rejection is the immune system’s response to the foreign graft and is categorized by the arm of the immune system involved: Acute Cellular Rejection (ACR): Mediated by T-lymphocytes infiltrating the myocardium. It is graded from 1R (mild) to 3R (severe) based on the extent of infiltration and myocyte damage. Antibody-Mediated Rejection (AMR): Mediated by B-cells producing donor-specific antibodies (DSAs) that attack the graft endothelium. It is diagnosed via histology (capillary swelling) and immunofluorescence (C4d staining). Diagnosis has historically relied on endomyocardial biopsy. However, non-invasive tools are gaining traction. Gene Expression Profiling (GEP) assesses the expression of genes associated with immune activation to rule out rejection in low-risk patients. Donor-Derived Cell-Free DNA (dd-cfDNA) measures the fraction of donor DNA in the recipient’s blood. Elevated levels suggest graft injury which can occur in both ACR and AMR. 4. What is the timeline of infectious risk and how does it guide prophylaxis? Infectious risk correlates with the net state of immunosuppression. < 1 Month (Nosocomial): Risks include surgical site infections, catheter-associated infections, and aspiration pneumonia. 1 – 6 Months (Opportunistic): This is the period of peak immunosuppression. Patients are at risk for PJP, CMV, Toxoplasma, and fungal infections. Prophylaxis typically includes Trimethoprim-Sulfamethoxazole (for PJP/Toxo) and Valganciclovir (for CMV, dependent on donor/recipient serostatus). > 6 Months (Community-Acquired): As immunosuppression is weaned, the risk profile shifts toward community-acquired respiratory viruses (Influenza, RSV) and pneumonias. However, patients with recurrent rejection requiring boosted immunosuppression remain at risk for opportunistic pathogens. 5. How does Cardiac Allograft Vasculopathy (CAV) differ from native CAD? CAV is the leading cause of late graft failure. Unlike the focal, eccentric plaques seen in native atherosclerosis, CAV is an immunologically driven process causing diffuse, concentric intimal hyperplasia. It affects both epicardial vessels and the microvasculature. Because of this diffuse nature, percutaneous coronary intervention (PCI) is often technically difficult and provides only temporary palliation. The only definitive treatment for severe CAV is re-transplantation. Surveillance is critical and is typically performed via annual coronary angiography, often using intravascular ultrasound (IVUS) to detect early intimal thickening before it is visible on the angiogram. References Costanzo MR, Dipchand A, Starling R, et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29(8):914-956. doi:10.1016/j.healun.2010.05.034. https://www.jhltonline.org/article/S1053-2498(10)00358-X/fulltext Kittleson MM, Kobashigawa JA. Cardiac Allograft Vasculopathy: Current Understanding and Treatment. JACC Heart Fail. 2017;5(12):857-868. doi:10.1016/j.jchf.2017.07.003. https://www.jacc.org/doi/10.1016/j.jchf.2017.07.003 Velleca A, Shullo MA, Dhital K, et al. The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2023;42(5):e1-e141. doi:10.1016/j.healun.2022.10.015. https://www.jhltonline.org/article/S1053-2498(22)02187-5/fulltext

How do you move patients from basic, insurance-driven dentistry to comprehensive care they truly value? In this episode of The Thriving Dentist Show, Gary Takacs and Naren Arulrajah unpack why traditional case presentation often fails—and what actually works instead. They explore the mindset shifts, relationship-building strategies, and marketing fundamentals that help patients understand, want, and accept comprehensive dentistry. From the role of hygiene and team communication to SEO, Google reviews, and patient trust, this conversation offers actionable insights for dentists who want to grow high-value care without feeling like they're "selling."

In this episode of the Healthy, Wealthy and Smart podcast, Dr. Karen Litzy interviews Dr. Aisha Akpabio D.D.S., a Detroit-based dentist and entrepreneur. They discuss the challenges and triumphs of being a female healthcare provider while running a business. Dr. Akpabio shares her journey from employee to owner of her own dental practice, the importance of design in healthcare, and the significance of representation in the field. They also address the balance between delivering high-quality care and managing business aspects, as well as the importance of self-care for longevity in the profession.   Takeaways   ·      It takes courage to bring people together in healthcare. ·      Transitioning from employee to entrepreneur requires a mindset shift. ·      Business education in dental school is minimal. ·      Delivering exceptional care justifies pricing. ·      Patients appreciate a personal touch over corporate practices. ·      Design can significantly impact patient experience. ·      Representation in healthcare matters for community trust. ·      Self-care is essential for longevity in the profession. ·      Balancing work and personal life is crucial. ·      Living in the moment is important for personal growth.   Chapters   ·      00:00 Introduction to Female Healthcare Entrepreneurship ·      02:58 Dr. Aisha Akpabio's Journey and Practice ·      05:51 Transitioning from Dentist to Entrepreneur ·      08:41 Navigating Healthcare Pricing and Value ·      12:05 Competing with Corporate Dental Practices ·      12:57 The Importance of Design in Healthcare ·      16:49 Legacy and Representation in Dentistry ·      20:02 Self-Care and Longevity in Dentistry   More About Dr. Akpabio:  Dr. Aisha Akpabio D.D.S. is a Detroit-based dentist, entrepreneur, and community advocate dedicated to smiles and systems of care. As the founder of Diamond Smiles Dentistry, she is redefining what it means to build a thriving dental practice rooted in wellness, accessibility, and neighborhood revitalization. A graduate of the Goldman Sachs 10,000 Small Business program, she leads with vision and heart, creating opportunities for growth in underserved communities while mentoring the next generation of healthcare professionals. Beyond dentistry, she is passionate about wellness, motherhood, and empowering others to build healthy, wealthy, and purpose-driven lives.   Resources from this Episode: Diamond Smiles Dentistry Website Instagram- Diamond Smiles Dentistry Facebook - Diamond Smiles Dentistry   Jane Sponsorship Information: Book a one-on-one demo here Mention the code LITZY1MO for a free month   Follow Dr. Karen Litzy on Social Media: Karen's Instagram Karen's LinkedIn   Subscribe to Healthy, Wealthy & Smart: YouTube Website Apple Podcast Spotify SoundCloud Stitcher iHeart Radio

Panthers QB Bryce Young joins the show to talk about what it was like playing against the two defenses that are in the Super Bowl, the Seahawks and Patriots. He also gives us his pick for who will win on Sunday. // Will the success that Sam Darnold has had over the last two seasons show teams that some patience is needed with these young QB’s? // Both the Seahawks and Patriots have had two weeks to prepare for the Super Bowl, is there any negative to having more time to prepare or is it more of a burden and opens the possibility of overthinking aspects of the game? // Sweeping the Dial: John Schneider was asked by NFL Network about returning to the sight of his viral sweaty armpits moment from Week 18. Roger Goodell was asked about the status of a possible Seahawks sale. Mike Macdonald was asked how it feels to go up against his hometown team

Juliana Stepanova: Trust Over Escalation — A Patient Approach to Difficult PO Relationships Read the full Show Notes and search through the world's largest audio library on Agile and Scrum directly on the Scrum Master Toolbox Podcast website: http://bit.ly/SMTP_ShowNotes.   "The team still believes it could be solved with proper communication to the PO. My idea is to really try, in a supportive way, to build trust, to encourage communication, and to come to the solution as a team altogether. This is like a win-win situation." - Juliana Stepanova   Juliana brings a challenge that many Scrum Masters will recognize: a Product Owner who doesn't want to be coached and whose behaviors are undermining Scrum rituals. The situation is complicated by organizational structure—the Scrum Master reports to the people department while the PO reports to the product department, creating misaligned directions with no common leadership thread.  The PO arrives at refinement meetings unprepared, writing user stories on the spot while eight team members sit idle for hours. When Juliana explores the root cause, she discovers the PO is genuinely overwhelmed with responsibilities outside the team. But here's the twist: this newly promoted PO is proud of the role and resistant to accepting help, preferring to say "just wait, I will manage it."  Rather than escalating—which Juliana notes would damage trust for years or potentially lose the PO entirely—she advocates for a patient, collaborative approach. The experiment she designs focuses on engaging more deeply with the PO's activities to understand which tasks could be delegated or eliminated, while continuing to build trust through support rather than confrontation. The team maintains hope that the PO will eventually accept help, choosing persistence over escalation.   In this segment, we talk about coaching Product Owners and building trust.   Self-reflection Question: When facing a resistant stakeholder, do you default to escalation, or do you invest in building the trust that enables genuine collaboration?   [The Scrum Master Toolbox Podcast Recommends]

This episode of EM Pulse dives into one of the most stressful scenarios in the ED: the febrile infant in the first month of life. Traditionally, a fever in this age group has meant an automatic “full septic workup,” including the dreaded lumbar puncture (LP). But times are changing. We sit down with experts Dr. Nate Kuppermann and Dr. Brett Burstein to discuss a landmark JAMA study that suggests we might finally be able to safely skip the LP in many of our tiniest patients. The Study: A Game Changer for Neonates Our discussion centers on a massive international pooled study evaluating the PECARN Febrile Infant Rule specifically in infants aged 0–28 days. While previous guidelines were conservative due to a lack of data for this specific age bracket, this study provides the evidence we've been waiting for. The Cohort: A large pool of infants across multiple countries. The Findings: The PECARN rule demonstrated an exceptionally high negative predictive value for invasive bacterial infections. The Big Win: The rule missed zero cases of bacterial meningitis. Defining the Danger: SBI vs. IBI The experts break down why we are shifting our terminology and our clinical focus. Serious Bacterial Infection (SBI)  Historically, this was a “catch-all” term including Urinary Tract Infections (UTIs), bacteremia, and meningitis. However, UTIs are generally more common, easily identified via urinalysis, and typically less life-threatening than the other two. Invasive Bacterial Infection (IBI)  This term refers specifically to bacteremia and bacterial meningitis. These are the “high-stakes” infections the PECARN rule is designed to rule out. Dr. Kuppermann notes that we should ideally view bacteremia and meningitis as distinct entities, as the clinical implications of a missed meningitis case are far more severe. The HSV Elephant in the Room One of the primary reasons clinicians hesitate to skip an LP in a neonate is the fear of missing Herpes Simplex Virus (HSV) infection. Low Baseline Risk: While the overall risk of HSV in a febrile infant is low, the risk of “isolated” HSV (meningitis without other signs or symptoms) is even rarer. Screening Tools: Most infants with HSV appear clinically ill. Clinicians can also use ALT (liver function) testing as a secondary screen – transaminase elevation is a common marker for systemic HSV. Clinical Judgment: If the baby is well-appearing, has no maternal history of HSV, no vesicles, and no seizures, the risk of missing HSV by skipping the LP is exceptionally low. Practical Application: Shared Decision-Making This isn’t just about the numbers—it’s about the parents. “Families don’t mind their babies being admitted… They do not want the lumbar puncture. It is the single most anxiety-provoking aspect of care.” — Dr. Brett Burstein The PECARN “Low-Risk” Criteria:  (Remember, this rule applies only to infants who are not ill-appearing.) Urinalysis: Negative Absolute Neutrophil Count (ANC): ≤ 4,000/mm³ Procalcitonin (PCT): ≤ 0.5 ng/mL The Bottom Line: If an infant is well-appearing and meets these criteria, physicians can have a nuanced conversation with parents about the risks and benefits of forgoing the LP, while still admitting the child for observation (often without empiric antibiotics) while cultures brew. Key Takeaways The “Well-Appearing” Filter: If an infant looks ill, the rule does not apply. These patients require a full workup, including an LP, regardless of lab results. Meticulous Physical Exam: Assess for a strong suck, normal muscle tone, brisk capillary refill, and any rashes or vesicles. History is Key: Always ask about maternal GBS/HSV status, pregnancy or birth complications, prematurity, sick contacts, and any changes in feeding, stooling or activity. Procalcitonin: PCT is the superior inflammatory marker for this rule. If your facility only offers traditional markers like CRP, the PECARN negative predictive value cannot be strictly applied. In the words of Dr. Kuppermann: “If you don’t have it, for God’s sakes, just get it! ALT to Screen for HSV: While not part of the official PECARN rule, our experts suggest that significantly elevated liver enzymes should raise suspicion for systemic HSV. Observe, Don’t Discharge: Being “low risk” does not mean the infant goes home. All infants ≤ 28 days still require admission for 24-hour observation and blood/urine cultures. We want to hear from you! Does this change how you approach febrile neonates in the ED? How do you handle shared decision-making with parents? Connect with us on social media @empulsepodcast or on our website ucdavisem.com. Hosts: Dr. Julia Magaña, Professor of Pediatric Emergency Medicine at UC Davis Dr. Sarah Medeiros, Professor of Emergency Medicine at UC Davis Guests: Dr. Nate Kuppermann, Executive Vice President and Chief Academic Officer; Director, Children’s National Research Institute; Department Chair, Pediatrics, George Washington University School of Medicine and Health Sciences Dr. Brett Burstein, Clinician-Scientist and Pediatric Emergency Medicine Physician at Montreal Children’s Hospital, McGill University Resources: Burstein B, Waterfield T, Umana E, Xie J, Kuppermann N. Prediction of Bacteremia and Bacterial Meningitis Among Febrile Infants Aged 28 Days or Younger. JAMA. 2026 Feb 3;335(5):425-433. doi: 10.1001/jama.2025.21454. PMID: 41359314; PMCID: PMC12687207“Hot” Off the Press: Infant Fever Rule “Hot” Off the Press: Infant Fever Rule Do I really need to LP a febrile infant with a UTI? PECARN Infant Fever Update: 61-90 Days Kuppermann N, Dayan PS, Levine DA, Vitale M, Tzimenatos L, Tunik MG, Saunders M, Ruddy RM, Roosevelt G, Rogers AJ, Powell EC, Nigrovic LE, Muenzer J, Linakis JG, Grisanti K, Jaffe DM, Hoyle JD Jr, Greenberg R, Gattu R, Cruz AT, Crain EF, Cohen DM, Brayer A, Borgialli D, Bonsu B, Browne L, Blumberg S, Bennett JE, Atabaki SM, Anders J, Alpern ER, Miller B, Casper TC, Dean JM, Ramilo O, Mahajan P; Febrile Infant Working Group of the Pediatric Emergency Care Applied Research Network (PECARN). A Clinical Prediction Rule to Identify Febrile Infants 60 Days and Younger at Low Risk for Serious Bacterial Infections. JAMA Pediatr. 2019 Apr 1;173(4):342-351. doi: 10.1001/jamapediatrics.2018.5501. PMID: 30776077; PMCID: PMC6450281. Pantell RH, Roberts KB, Adams WG, Dreyer BP, Kuppermann N, O’Leary ST, Okechukwu K, Woods CR Jr; SUBCOMMITTEE ON FEBRILE INFANTS. Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old. Pediatrics. 2021 Aug;148(2):e2021052228. doi: 10.1542/peds.2021-052228. Epub 2021 Jul 19. Erratum in: Pediatrics. 2021 Nov;148(5):e2021054063. doi: 10.1542/peds.2021-054063. PMID: 34281996. ****Thank you to the UC Davis Department of Emergency Medicine for supporting this podcast and to Orlando Magaña at OM Productions for audio production services.  

This week, we look at new evidence on oral cholesterol-lowering therapy, the evolving role of beta-blockers after myocardial infarction, and advances in breast and prostate cancer treatment. We review the inherited risk of coronary disease. We also work through a revealing diagnostic case in a young woman and reflect on science under pressure, corporatized insurance, the reach of FDA law, and what it means to live with life-sustaining technology.

Congress has passed, and President Trump has signed, a major government funding bill that includes a wide range of health care policies, from telehealth extensions and hospital-at-home programs to long-sought reforms targeting pharmacy benefit managers. But alongside those wins, the legislation also raises serious questions about the future direction of federal health policy. In this episode of The Health Advocates, Steven Newmark breaks down what the new spending package actually does for patients, what it leaves unresolved, and why some lawmakers and advocates are uneasy about increasing funding for federal health agencies under current leadership. The conversation explores how these decisions affect access to care, drug costs, public health programs, and trust in health institutions. Whether you’re a patient, caregiver, clinician, or advocate, this episode offers a clear, practical look at how congressional budget decisions shape health care on the ground, and why continued engagement and oversight matter more than ever. Contact Our HostSteven Newmark, Chief of Policy at GHLF: snewmark@ghlf.orgA podcast episode produced by Ben Blanc, Director, Digital Production and Engagement at GHLF.We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to podcasts@ghlf.orgListen to all episodes of The Health Advocates on our website or on your favorite podcast channel.See omnystudio.com/listener for privacy information.

What if the most powerful cancer treatments already exist — but aren't being offered because they fall outside the guidelines?In this episode of Integrative Cancer Solutions, Dr. Michael Karlfeldt sits down with world-renowned interventional radiologist and oncology innovator Dr. Syed Hasnain Haider-Shah to explore why modern cancer care often prioritizes protocols over patients. From catheter-directed chemotherapy and tumor embolization to immune-based strategies, photobiomodulation, and precision nutrition, Dr. Shah reveals how advanced cancer treatments are being used globally — especially in China — while remaining largely inaccessible in the U.S.This conversation dives deep into the limitations of chemotherapy and radiation, the intelligence of cancer stem cells, immune system suppression, cancer cachexia, and why integrative, individualized approaches give patients their best chance at long-term survival. If you or someone you love is navigating a cancer diagnosis and searching for real options beyond “standard of care,” this episode is essential listening.Key Takeaways:5:20 Radiation therapy risks and how to support recovery nutritionally11:46 Why systemic chemotherapy often fails and selects for aggressive cancer cells12:17 Catheter-directed chemotherapy: targeting tumors without poisoning the body16:25 The immune system as the most powerful anti-cancer weapon26:37 Tumor embolization: starving cancer by cutting off its blood supply34:50 Why advanced cancer therapies thrive in China but are restricted in the U.S.Resources Mentioned:Williams Cancer Institute (Mexico) – https://williamscancerinstitute.comPhotobiomodulation / Intravenous Light Therapy (General Overview) – https://pubmed.ncbi.nlm.nih.gov Want to guest on our shows?Calendly Link for Integrative Lyme Solutions: https://calendly.com/drmichaelk/integrative-lyme-solutions-podcast-interviewCalendly Link for Integrative Cancer Solutions: https://calendly.com/drmichaelk/podcast-interviewCalendly Link for Dr. K Show: https://calendly.com/drmichaelk/dr-k-show-interview Breaking Free From Lyme: A Comprehensive Guide to Healing and Recovery-URL: https://store.thekarlfeldtcenter.com/products/breaking-free-from-lyme-Price: $24.99-Discount Code: LYMEPODCASTUnleashing 10X Power: A Revolutionary Approach to Conquering Cancer-URL: https://store.thekarlfeldtcenter.com/products/unleashing-10x-power-Price: $24.99-Discount Code: CANCERPODCAST1Healing Within: Unraveling the Emotional Roots of Cancer-URL: https://store.thekarlfeldtcenter.com/products/healing-within-Price: $24.99-Discount Code: CANCERPODCAST2The Science and Spirit of Transformation: A Holistic Guide to Elevating Health, Consciousness, and Purpose-URL: https://store.thekarlfeldtcenter.com/products/the-science-and-spirit-of-transformation-Price: $24.99-Discount Code: DRKSHOWPODCAST -----------------------------------------------A Better Way to Treat Cancer: A Comprehensive Guide to Understanding, Preventing and Most Effectively Treating Our Biggest Health ThreatGrab my book here: https://www.amazon.com/dp/B0CM1KKD9X?ref_=pe_3052080_397514860 Unleashing 10X Power: A Revolutionary Approach to Conquering CancerGet it here: https://store.thekarlfeldtcenter.com/products/unleashing-10x-powerPrice: $24.99100% Off Discount Code: CANCERPODCAST1 Healing Within: Unraveling the Emotional Roots of CancerGet it here: https://store.thekarlfeldtcenter.com/products/healing-withinPrice: $24.99100% Off Discount Code: CANCERPODCAST2-----------------------------------------------Integrative Cancer Solutions was created to instill hope and empowerment. Other people have been where you are right now and have already done the research for you. Listen to their stories and journeys and apply what they learned to achieve similar outcomes as they have, cancer remission and an even more fullness of life than before the diagnosis. Guests will discuss what therapies, supplements, and practitioners they relied on to beat cancer. Once diagnosed, time is of the essence. This podcast will dramatically reduce your learning curve as you search for your own solution to cancer. To learn more about the cutting-edge integrative cancer therapies Dr. Karlfeldt offer at his center, please visit www.TheKarlfeldtCenter.com

In this episode, Leslie Davis, PhD, ANP, FAANP, and nurse practitioner Linda Wellman discuss ANOCA/INOCA—angina or ischemia with no obstructive coronary arteries—an underdiagnosed condition affecting millions. Through expert commentary and lived experience, the conversation highlights why "normal" cardiac catheterization results can still miss serious heart disease. Listeners will hear Linda's journey as a patient with ANOCA, learn about diagnostic challenges, treatment considerations, and the critical role nurse practitioners play in advocacy and care. While this condition affects both men and women, women with symptoms are more likely to be dismissed by health care providers, leading to delays in diagnosis and treatment. This episode calls for greater awareness to reduce delays, improve outcomes, and support patients whose symptoms have too often been dismissed.

Welcome to Resiliency Radio with Dr. Jill Carnahan, where today's episode takes you behind the scenes of ketamine therapy—one of the most promising and misunderstood breakthroughs in modern mental health care. Dr. Jill is joined by Dr. Jennifer Ellice, a board-certified emergency medicine physician and founder of Golden Afternoon Clinic. In this candid and eye-opening conversation, Dr. Ellice shares her unconventional journey from emergency medicine burnout during COVID to specializing in trauma-informed ketamine therapy for treatment-resistant depression, anxiety, PTSD, chronic pain, and suicidal ideation.

See omnystudio.com/listener for privacy information.

Physical therapists Ziya Altug and Shirish Sachdeva discuss their article "Why your clinic waiting room may affect patient outcomes." Ziya and Shirish explore how the ambiance of a medical office significantly impacts patient anxiety and emotional well-being before treatment even begins. They examine evidence-based strategies to transform functional spaces into healing environments using calming music, nature-inspired art, and ergonomic furniture design. The conversation highlights specific needs for pediatric patients and how transparency through technology can build trust between patients and health care providers. Understanding these environmental factors allows clinics to foster a sense of safety and improve the overall care experience through intentional design interventions. Discover how simple changes to a waiting area can set a positive tone for recovery and comfort. Partner with me on the KevinMD platform. With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Whether you need a sponsored article, email campaign, video interview, or a spot right here on the podcast, I offer the trusted space your brand deserves to be heard. Let's work together to tell your story. PARTNER WITH KEVINMD → https://kevinmd.com/influencer SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Recorded live at the NTL Summit in Miami, this episode features Cara Rosenthal, co-founder and Chief Legal & Strategy Officer of Expert Radiology, a Puerto Rico–based teleradiology group with a national presence. Cara breaks down their proprietary, patient-first MRI reporting system—featuring colorized key images, side-by-side comparisons, and detailed medical illustrations designed to make injuries instantly understandable. She shares why comprehension leads to better patient compliance, how these reports become powerful built-in demonstratives for injury cases, and what's next as their patent and new SaaS feature expand visual reporting to any radiologist's report.

Bill Thach has had 9 lines of treatment, over 1,000 doses of chemo, and more scans than an airport. He runs ultramarathons for fun. He jokes about being his own Porta Potty. He became a father, then got cancer while his daughter was 5 months old. Today she is 8. He hides the worst of it so she can believe he stands strong, even when he knows that hiding has a cost.We talk about the illusion of strength, what it means to look fine when your body is falling apart, and how a random postcard in an MD Anderson waiting room led him to Man Up to Cancer, where he now leads Diversity and AYA Engagement. Fatherhood. Rage. Sex. Denial. Humor. Survival. All that and why the words good morning can act like a lifeline.RELATED LINKSFight Colorectal CancerCURE TodayINCA AllianceMan Up to CancerWeeViewsYouTubeLinkedInFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Pediatric hospitals are one of the most important segments in the industry to watch right now. Although children's hospitals make up only 5% of total hospital market share, more than 40% of U.S. children rely on Medicaid, leaving pediatric organizations disproportionately exposed as the Medicaid-related provisions of the One Big Beautiful Bill Act take effect. The pressures inside pediatric care were mounting even before this moment. After years of outperforming adult hospitals, children's hospitals have seen margins fall from double digits to just 1% last year. Rising bad debt, higher supply and labor costs, a rapid shift toward lower margin outpatient care, and emerging challenges like declining birth rates and vaccine policy upheaval have created a perfect financial storm. While some of these dynamics are unique to pediatrics, the sector also offers an early warning signal for the rest of healthcare — and an opportunity to translate lessons across both worlds. In this episode, host Abby Burns and Advisory Board expert Vidal Seegobin break down why pediatric leaders must simultaneously manage immediate-term margin pressure, prepare for a more ambulatory-dominant model, and futureproof their organizations amid shifting demographics. Vidal also shares actionable steps leaders can take now, along with the critical lessons pediatric hospitals offer the wider healthcare ecosystem. We're here to help: 5 insights on the state of pediatric hospitals today 12 things CEOs need to know in 2026 The State of the Healthcare Industry in 2026 Read Advisory Board's 2026 research agenda 3 trends shaping healthcare in 2026 (and how to respond) 278: Dr. Emily Oster on fighting misinformation and rebuilding trust in healthcare 277: Patient distrust is costing you. Here's how to rebuild it. Learn how outpatient shifts can impact your organization by using Advisory Board's Market Scenario Planner tool. Sign up today for this Optum Health Webinar: Scaling your EHR: How Optum Health built an enterprise platform to redefine care delivery. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Artificial intelligence is already transforming healthcare—often in ways patients don't even realize. Listen as Michael sits down with Dr. Anthony Mazzarelli, physician, lawyer, and co-CEO of Cooper University Health Care, for a wide-ranging conversation about how AI is being used in medicine today and where it's headed next. They explore everything from AI “ambient scribing” and clinical decision support to medical liability, patient consent, privacy, bias, and whether AI will ultimately strengthen—or weaken—the doctor-patient relationship. Dr. Mazzarelli explains why he believes AI can reduce burnout, improve care, and even restore compassion in medicine—if it's used responsibly and with humans firmly in the loop. A thoughtful, practical discussion about one of the most consequential shifts in modern healthcare. Original air date 24 November 2025. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

How can physicians and their teams deliver exceptional patient experiences, even when things go wrong?In this episode of Succeed In Medicine Podcast, Dr. Bradley Block interviews Shep Hyken, as he shares practical strategies for elevating patient care, emphasizing that "amazing" service doesn't require grand gestures, it's about being slightly better than average, consistently. Drawing parallels from hospitality giants like the Ritz-Carlton, he explains how using patients' names, setting clear expectations, and leveraging technology like patient portals can reduce friction and build loyalty.The conversation dives into handling "moments of misery," such as late appointments or scheduling mishaps, with a five-step process: acknowledge the issue, apologize, discuss resolutions, own the problem, and act with urgency. Shep also stresses the importance of creating a patient-focused culture through leadership, training, and hiring for personality fit. He introduces concepts like "destination employment" to foster employee fulfillment and uniqueness, ensuring staff feel empowered to deliver compassionate care. Ultimately, Shep reinforces that patients compare healthcare experiences to top-tier service in any industry, so practices must prioritize convenience, empathy, and proactive communication to stand out.Three Actionable TakeawaysDefine "Amazing" as Consistent Excellence: Aim to be just 10% better than average every time—through friendly interactions, using patients' names, and meeting expectations reliably—to create loyalty without over-the-top efforts.Turn Complaints into Opportunities: Use a five-step process for moments of misery: acknowledge the issue, apologize, discuss fixes with options, own the resolution personally, and act urgently to rebuild trust.Build a Patient-Focused Culture: Start with leadership by defining a one-sentence vision for the experience, communicate it repeatedly, train staff ongoingly, role-model behaviors, defend the standards, and celebrate successes to empower your team.About the Show:Succeed In Medicine covers patient interactions, burnout, career growth, personal finance, and more. If you're tired of dull medical lectures, tune in for real-world lessons we should have learned in med school!About the Guest:Shep Hyken is a customer service and experience expert, award-winning keynote speaker, researcher, and New York Times and Wall Street Journal bestselling author. He has been quoted in hundreds of publications and is the author of eight books, including his most recent, "I'll Be Back: How to Get Customers to Come Back Again and Again." Shep works with companies and organizations that want to build loyal relationships with their customers and employees.LinkedIn: linkedin.com/in/shephykenWebsite: hyken.comAbout the Host:Dr. Bradley Block – Dr. Bradley Block is a board-certified otolaryngologist at ENT and Allergy Associates in Garden City, NY. He specializes in adult and pediatric ENT, with interests in sinusitis and obstructive sleep apnea. Dr. Block also hosts Succeed In Medicine podcast, focusing on personal and professional development for physiciansWant to be a guest?Email Brad at brad@physiciansguidetodoctoring.com  or visit www.physiciansguidetodoctoring.com to learn more!Socials:@physiciansguidetodoctoring on Facebook@physicianguidetodoctoring on YouTube@physiciansguide on Instagram and Twitter   This medical podcast is your physician mentor to fill the gaps in your medical education. We cover physician soft skills, charting, interpersonal skills, doctor finance, doctor mental health, medical decisions, physician parenting, physician executive skills, navigating your doctor career, and medical professional development. This is critical CME for physicians, but without the credits (yet). A proud founding member of the Doctor Podcast Network!Visit www.physiciansguidetodoctoring.com to connect, dive deeper, and keep the conversation going. Let's grow! Disclaimer:This podcast is for informational purposes only and is not a substitute for professional medical, financial, or legal advice. Always consult a qualified professional for personalized guidance. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

A Prayer for Love That is Patient by Rachael AdamsWhat if God isn’t rushing you… because He’s patiently loving you?In today's episode by Rachael Adams, we explore the patience of God and how He gently draws us into deeper relationship with Him over time. From fear-based belief to friendship with God—Rachael reminds us that God is not in a hurry. He lovingly reveals Himself layer by layer, meeting us where we are and inviting us to know Him more fully. Reference: 2 Peter 3: 9 Prayer: Father, I'm grateful for your patience with me. You have always pursued me and waited for me to come to you. Thank you for welcoming me with open arms. May I be patient with myself and not rush the process of sanctification. Help me to extend the same forbearance to the people in my life. In Jesus' name, amen. LINKS: Connect with Rachael Adams Order Everyday Prayers for Love Follow Everyday Prayers @MillionPrayingMoms Get today's devotion and prayer in written form to keep for future use! Support the ministry with your $5 monthly gift through Patreon. Discover more Christian podcasts at LifeAudio.com and inquire about advertising opportunities at LifeAudio.com/contact-us Discover more Christian podcasts at lifeaudio.com and inquire about advertising opportunities at lifeaudio.com/contact-us.

In this episode, Dr. Andy Anderson, Chief Medical Officer and Chief Quality Officer at RWJBarnabas Health, shares how the system is improving mortality outcomes and patient experience through rapid response teams, standardized best practices, and a strong culture of accountability. He discusses strategies for scaling success, coordinating care, and fostering growth across the health system.

What can you expect as a local business on Instagram in 2026? Today's episode features my conversation with Michelle Grasek on the Acupuncture Marketing School podcast. We dive into Instagram marketing strategies to grow your local brick-and-mortar business, as well as build a community. Review full show notes and resources at mollycahill.com/podcastMentioned in this Episode:Episode 112 Instagram Marketing Tips for Acupuncturists with Molly Cahill: michellegrasek.com/instagram-marketing-tips-for-acupuncturistsUse coupon code AMS to save $200 on the Holistic Marketing Hub: holisticmarketinghub.com/enrollConnect with Michelle:Website: michellegrasek.comInstagram: instagram.com/michellegrasekConnect with Molly:Holistic Marketing Hub holisticmarketinghub.com/enrollInstagram: instagram.com/mollyacahill

Rob Suárez, Vice President and Chief Information Security Officer at CareFirst BlueCross BlueShield joins Ann on this week's episode of Afternoon Cyber Tea. In the conversation, Rob shares how his career path and personal philosophy have shaped a mission-driven approach to cybersecurity that places patient trust, safety, and privacy at the center of every decision. He discusses the unique challenges of securing a deeply interconnected healthcare ecosystem, the critical role of culture and cyber literacy across organizations, and why transparency and resilience are essential during incidents. The episode also explores secure-by-design principles, the ethical use of AI in healthcare, and how the CISO role is evolving toward a broader focus on trust, collaboration, and human impact.     Resources:  View Rob Suárez on LinkedIn    View Ann Johnson on LinkedIn     Related Microsoft Podcasts:   Microsoft Threat Intelligence Podcast   The BlueHat Podcast    Uncovering Hidden Risks            Discover and follow other Microsoft podcasts at microsoft.com/podcasts       Afternoon Cyber Tea with Ann Johnson is produced by Microsoft, Hangar Studios and distributed as part of N2K media network.  

In this episode, Antonia and Andrew discuss the February 4, 2026 issue of JBJS, along with an added dose of entertainment and pop culture. Listen at the gym, on your commute, or whenever your case is on hold! Link: JBJS website: https://jbjs.org/issue.php Sponsor: This episode is brought to you by JBJS Clinical Classroom. Subspecialties: Hip, Knee, Education & Training, Orthopaedic Essentials, Spine, Trauma, Basic Science Chapters (00:00:03) - Your Cases on Hold, Episode 99(00:01:49) - Orthopedic Board Certification Examination(00:02:52) - Headlines in Orthopedics: The Year of Innovation(00:04:09) - Nonunion Fractures: Risk Factors and Bayesian Analysis(00:16:10) - Knee muscle changes in ACL deficient patients who didn't undergo surgery(00:21:10) - Tourniquet use and 3-D cement penetration during primary(00:29:31) - Intimate Partner Violence in orthopedic trauma(00:38:55) - Honorable Mention

Informed Dissent with Dr. Jeff Barke and Dr. Mark McDonald – Trust in medicine and public institutions is unraveling as bureaucracy, money, and ideology replace evidence and transparency. From board certification to pharmaceutical influence and informed consent, patients pay the price. Rebuilding trust requires honesty, accountability, and restoring cultural balance that allows families, children, and society to thrive...

Informed Dissent with Dr. Jeff Barke and Dr. Mark McDonald – Trust in medicine and public institutions is unraveling as bureaucracy, money, and ideology replace evidence and transparency. From board certification to pharmaceutical influence and informed consent, patients pay the price. Rebuilding trust requires honesty, accountability, and restoring cultural balance that allows families, children, and society to thrive...

Dr. Andy Southerland talks with Dr. Dipika Aggarwal as she shares her profound journey as both a physician and a patient. After battling stage four colon cancer, she faced a stroke that changed her life.  Disclosures can be found at Neurology.org. 

🧭 REBEL Rundown 🗝️ Key Points 💉 Hydrocortisone Saves Lives:The 2023 Cape Cod Trial (NEJM) showed a clear mortality benefit and reduced need for intubation in severe CAP patients treated with hydrocortisone.📊 Guidelines Are Catching Up:The SCCM (2024) and ERS now recommend steroids for severe CAP, while ATS/IDSA updates are still pending.🔥 Redefining “Severe”:Patients requiring high FiO₂ (>50%), noninvasive or mechanical ventilation, or PSI >130 meet criteria for steroid therapy — even outside the ICU.🍬 Main Risk = Hyperglycemia:Elevated glucose was the most consistent adverse effect, but rates of GI bleed and secondary infection were not increased.🧭 Early, Targeted Use Matters:Start hydrocortisone within 24 hours of identifying severity — especially in patients with high CRP (>150) or strong inflammatory response. Click here for Direct Download of the Podcast. 📝 Introduction Corticosteroids have long sparked debate in the treatment of bacterial pneumonia — once viewed with skepticism, now increasingly supported by high-quality evidence. In this episode, Dr. Alex Chapa joins the REBEL Core Cast team to explore how the 2023 Cape Cod Trial (NEJM) reshaped practice and guideline recommendations for severe community-acquired pneumonia (CAP). 📖 Historical Context & Long-Standing Skepticism For decades, the use of steroids in pneumonia was controversial.Early Use: Steroids entered practice in the 1940s and 50s for autoimmune inflammation, but there was immediate hesitation regarding secondary superinfections.Mixed Data: From the 1980s to the 2000s, small studies emerged on severe pneumonia and ARDS, but the data was inconsistent. Different trials used varying definitions of “severe” pneumonia and different C-reactive protein (CRP) cutoffs, making the data “spread” and easy to “cherry pick” to support or deny a benefit.Past Guidelines: This uncertainty was reflected in official guidelines:2007 (ATS/IDSA): The American Thoracic Society and the Infectious Diseases Society of America did not address the topic due to insufficient data.2019 (ATS/IDSA): Pre-COVID, the guidelines recommended against using corticosteroids in severe CAP. They acknowledged no benefit for non-severe pneumonia, but the data for severe pneumonia was considered too weak to endorse.Pre-Trial Consensus: Prior to 2023, the consensus was to avoid steroids in non-severe pneumonia, while severe pneumonia remained a “gray area” with no treatment showing a clear mortality difference. 📜 The Landmark Cape Cod Trial (NEJM 2023) The Cape Cod trial, published in the New England Journal of Medicine in 2023, reignited the discussion by providing robust, positive data.Trial Design: Phase 3, multi-center, double-blind, randomized, controlled trial.Intervention: 800 patients randomized to two groups, Hydrocortisone as a continuous infusion (200mg/day) versus a placebo infusion.Taper: On day 4, clinicians would decide whether to continue the infusion or begin a taper based on clinical response.Population: Patients with severe CAP, defined by meeting at least one of the following criteria:Pneumonia Severity Index (PSI) > 130.O2 by FiO2 ratio < 300.Need for mechanical or non-invasive ventilation (with PEEP ≥ 5).Need for high FiO2 (>50%) via non-rebreather or heated high flow.Primary Outcomes: Death for any cause 6.2% (hydrocortisone) vs 11.9% (placebo)Secondary outcomes:Death from any cause at 90 days 9.3% (hydrocortisone) vs 14.7% (placebo)Endotracheal intubation 18% (hydrocortisone) vs 29% (placebo)Hospital-acquired infections 9.8% (hydrocortisone) vs 11.1% (placebo)Gastrointestinal bleeding 2.3% (hydrocortisone) vs 3.3% (placebo)Vasopressor initiation by day 28 15.3% (hydrocortisone) vs 25.0% (placebo)Key Findings: The trial demonstrated superiority for hydrocortisone 📋 Updated Guidelines & Current Practice The Cape Cod trial, along with subsequent meta-analyses, has begun to change official recommendations.Society of Critical Care Medicine (SCCM): In 2024, an SCCM expert panel, reviewing the Cape Cod trial and 18 others, strongly recommended corticosteroids for severe CAP. They concluded that steroids reduce mortality and the need for mechanical ventilation.Meta-Analysis (Smit et al.): A 2024 meta-analysis in Lancet Respiratory confirmed the 30-day mortality benefit.European Respiratory Society (ERS): The ERS has issued a recommendation to use steroids for severe pneumonia but still urges caution regarding side effects.ATS/IDSA: As of the podcast recording, the ATS/IDSA had not yet updated their 2019 guidelines. 🛠️ Practical Application for Clinicians Defining “Severe” CAP: The key is to identify patients who qualify as “severe”. This can be done using:Scoring Tools: The PSI is the best validated tool for mortality but is cumbersome. Simpler tools like CURB-65 or SMART-COP are practical and acceptable for defining severity. 2023 meta-analysis from by Zaki et al showed both work well, but CURB-65 has better mortality prediction early on.Cape Cod Criteria: Any patient meeting the trial’s inclusion criteria (e.g., high-flow O2, non-invasive ventilation) qualifies, regardless of location (ED, floor, or ICU).Biomarkers: While not required, a CRP level was used in many studies. A CRP > 150 (Cape Cod) or > 204 (Smit meta-analysis) strongly indicates severe inflammation that would benefit from steroids.Clinical Judgment: A patient who looks “sick,” has “soft” blood pressure, or has dense infiltrates and high oxygen needs (e.g., >50% FiO2 on high flow) is a candidate.Adverse Effects:Hyperglycemia: This was the most significant risk identified, with rates between 6-12%. This is a primary concern, especially in patient populations with high BMI.GI Bleed & Secondary Infection: Fears of these side effects, which contributed to historical skepticism, were not borne out in the Cape Cod trial. The data does not support being overly concerned.Other Side Effects: Mood changes, delirium, insomnia, and agitation in the elderly are known side effects of steroids that were not specifically addressed in the trial but remain clinical concerns. 🔄 Clinical Pathway for Steroids in Severe CAP Unanswered Questions & Future Research Possible remaining questions:Biomarkers: Can we find a more precise CRP level to distinguish moderate from severe disease? Could other markers like ferritin or IL-6 be used? Dosing & Tapering: How much immunomodulation is needed, and when is it truly safe to taper?Gender Differences: Early data suggests females may respond better to steroids and experience fewer side effects. The question of female patients with severe CAP require less corticosteroids needs further exploration. 👉 Clinical Bottom Line The current literature, spearheaded by the Cape Cod trial, now supports the use of corticosteroids in severe community-acquired pneumonia. The best evidence currently points to hydrocortisone, started early (within 24 hours) after severity is identified using a validated tool. While hyperglycemia is a risk, the previous fears of GI bleeding and secondary infections were not substantiated in recent, rigorous trials. 📚 References Chapa-Rodriguez A, Abou-Elmagd T, O’Rear C, Narechania S. Do patients with severe community-acquired bacterial pneumonia benefit from systemic corticosteroids?. Cleve Clin J Med. 2025;92(10):600-604. PMID: 41033846Dequin PF, Meziani F, Quenot JP, et al. Hydrocortisone in Severe Community-Acquired Pneumonia. N Engl J Med. 2023;388(21):1931-1941. PMID: 36942789Chaudhuri D, Nei AM, Rochwerg B, et al. 2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia. Crit Care Med. 2024;52(5):e219-e233. PMID: 38240492 Post Peer Reviewed By: Marco Propersi, DO (Twitter/X: @Marco_propersi), and Mark Ramzy, DO (X: @MRamzyDO) 👤 Show Notes Alex Chapa, MD PGY 5 Pulmonary Critical Care Fellow Cape Fear Valley Medical Center Fayetteville NC 🔎 Your Deep-Dive Starts Here REBEL Core Cast 149: Review of Corticosteroids in Community-Acquired Pneumonia Corticosteroids have long sparked debate in the treatment of bacterial ... Thoracic and Respiratory Read More The post REBEL Core Cast 149: Review of Corticosteroids in Community-Acquired Pneumonia appeared first on REBEL EM - Emergency Medicine Blog.

The most effective way to drive change in healthcare is to focus on what remains constant: serving patients. In this episode, sponsored by Amgen. Leandro Boer, Vice President of US Medical and General Medicines at Amgen, discusses how the company is reimagining care delivery to enhance access and outcomes, particularly for underserved populations. He explains how precision medicine, multi-omics, and advanced data use are driving innovation and preventing “data waste,” while Amgen invests heavily in R&D, including a $600 million Innovation and Discovery Science Center. Leandro highlights the role of technology in accelerating clinical trials through machine learning and anticipates three major shifts within the next five years: faster drug development, reduced administrative burden through the use of AI, and improved patient identification via care pathway automation. He also highlights Amgen's goal to reduce cardiovascular events by 50% by 2030, the importance of diverse clinical representation through the RISE initiative, and the company's commitment to employee well-being as the foundation for improved patient care. Tune in and learn how innovation, equity, and purpose-driven leadership are transforming the future of healthcare! Resources: Connect with and follow Leandro Boer on LinkedIn. Follow Amgen on LinkedIn and explore their website.

This week, we kicked off our sermon series Established as we take a look at the different stories throughout 1 Samuel. This week, we looked at the story of Hannah and how she was barren but rooted in God and found His faithfulness amidst disappointment.1 Samuel 1:1-2 Genesis 2:24 Therefore a man shall leave his father and his mother and hold fast to his wife, and the two shall become one flesh.Matthew 19:4-6  He (Jesus) answered, “Have you not read that He who created them from the beginning made them male and female, 5  and said, ‘Therefore a man shall leave his father and his mother and hold fast to his wife, and the two shall become one flesh'?  6  So they are no longer two but one flesh. What therefore God has joined together, let not man separate.”  I SAMUEL 1:3-18 Being Established DURING Great Disappointment1. Continue in Prayer 10, 12, 13, 16, 26, 27.2. Endure in all Things 183. Worship the Lord  19  1 SAMUEL 1:19-204. Patient in Trust  20I SAMUEL 1:21-28I SAMUEL 2:1-10Christ is the promised King who will establish His people by His victory over death.

Drs. Coombs and Danilov explore how to optimally sequence covalent BTK inhibitors, non‑covalent BTK inhibitors (such as pirtobrutinib), and venetoclax-based regimens for relapsed CLL, emphasizing real-world data and emerging trial results. They highlight that treatment choices hinge on prior response depth and duration, tolerability, mutational profile, and the need to preserve future options and clinical trial eligibility.

Unity Without Compromise with Dr. Steven LaTulippe – Doctors often dread treating central pain patients, not out of cruelty, but fear, ignorance, liability, and systemic pressure. Central pain exposes deep failures in modern medicine, from profit-driven care to inadequate training. Understanding these realities empowers patients to navigate care wisely, build trust, and become effective partners in their own healing journey...

Most people battling addiction never get a second chance. Nick Reiner got eighteen of them. Eighteen trips to rehab facilities reportedly costing $60,000 a month. Private yoga instructors. Family therapists. A guesthouse on a $13.5 million Brentwood estate where he could land softly every time he fell. Rob and Michele Reiner never stopped showing up for their son. On December 14, 2025, they were found stabbed to death in their home. Nick was arrested that night and now faces two counts of first-degree murder. But this story isn't just about entitlement, enabling, and what happens when love without boundaries meets zero accountability. It's about a $42 billion addiction treatment industry designed to fail. The 28-day program isn't based on neuroscience—it's based on what insurance agreed to pay in the 1970s. The brain doesn't heal in 28 days. But the invoice does. Sixty percent of patients relapse within 30 days of discharge. Luxury rehabs have no obligation to track—let alone report—whether their patients actually get better. Patients learn to game the system. Facilities profit whether they live or die. We trace Nick's trajectory from childhood tantrums that derailed family yoga sessions to violent outbursts in rehab at fifteen, from destroying his parents' guesthouse on meth to a 2020 mental health conservatorship, from allegedly terrorizing guests at Conan O'Brien's Christmas party to the murders less than 24 hours later. A rehab roommate said he "knew exactly who it was" when he heard the news. A yoga instructor wrote a children's book about his behavior. Nick made disturbing admissions on the Dopey podcast about violence, theft, and moral bankruptcy. The Reiners aren't unique. They're a pattern. Parents bankrupted by hope. Kids cycling through treatment. And an industry that takes the money regardless of outcome.#NickReiner #RobReiner #MicheleReiner #RehabIndustry #AddictionCrisis #ReinerCase #SystemFailure #BrentwoodMurder #Parricide #TrueCrimeJoin Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspodInstagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/tonybpodListen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872This publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.

In this conversation, Kristen Keller shares her journey from a political science background to her current role in operations at Tampa General Hospital. She discusses the challenges of being a working mom, the importance of community support, and the need for coordination in healthcare to improve mental health outcomes. Kristen emphasizes the significance of patient advocacy and shares her experiences in Tallahassee, where she engages with lawmakers to promote healthcare initiatives. She concludes with valuable advice for parents struggling to balance their responsibilities.As You Listen00:00 Finding Community as a Working Parent 06:16 Navigating Work-Life Harmony 10:53 The Importance of Coordination in Healthcare 13:30 Advocacy and Patient Stories 16:53 Advice for Struggling Parents

God’s Plan for Your Growth 2 Peter 1:3-4 By his divine power, God has given us everything we need for living a godly life. We have received all of this by coming to know him, the one who called us to himself by means of his marvelous glory and excellence. 4 And because of his glory and excellence, he has given us great and precious promises. These are the promises that enable you to share his divine nature and escape the world’s corruption caused by human desires. (NLT) 2 Peter 1:5 In view of all this, make every effort to respond to God’s promises. Supplement your faith… (NLT) 2 Peter 1:5 In view of all this, make every effort to respond to God’s promises. Supplement your faith with a generous provision of moral excellence… (NLT) 1. Moral Excellence Ephesians 2:10 For we are God’s masterpiece. He has created us anew in Christ Jesus, so we can do the good things he planned for us long ago. (NLT) Colossians 3:23 Whatever you do, work at it with all your heart, as working for the Lord, not for human masters. (NIV) 2. Knowledge 2 Peter 1:5 Supplement your faith with a generous provision of moral excellence, and moral excellence with knowledge. (NLT) 2 Peter 3:18 Rather, you must grow in the grace and knowledge of our Lord and Savior Jesus Christ.  (NLT) 3. Self-control 2 Peter 1:5-6 Supplement your faith with a generous provision of moral excellence, and moral excellence with knowledge, 6 and knowledge with self-control. (NLT) Proverbs 25:28 A person without self-control is like a city with broken-down walls. (NLT) Titus 2:11-12 For the grace of God has appeared that offers salvation to all people. 12 It teaches us to say “No” to ungodliness and worldly passions, and to live self-controlled, upright and godly lives in this present age. (NIV) 4. Patient endurance 2 Peter 1:5-6 Supplement your faith with a generous provision of moral excellence, and moral excellence with knowledge, 6 and knowledge with self-control, and self-control with patient endurance. (NLT) Hebrews 6:19 We have this hope as an anchor for the soul, firm and secure. (NIV) 5. Godliness 2 Peter 1:5-7 Supplement your faith with a generous provision of moral excellence, and moral excellence with knowledge, 6 and knowledge with self-control, and self-control with patient endurance, and patient endurance with godliness. (NLT) 2 Peter 2:3 His divine power has given us everything we need for a godly life. (NIV) 6. Brotherly affection 2 Peter 1:5-7 Supplement your faith with a generous provision of moral excellence, and moral excellence with knowledge, 6 and knowledge with self-control, and self-control with patient endurance, and patient endurance with godliness, 7 and godliness with brotherly affection. (NLT) 1 John 4:20 If someone says, “I love God,” but hates a fellow believer, that person is a liar; for if we don’t love people we can see, how can we love God, whom we cannot see? (NLT) Hebrews 13:1 Keep on loving each other as brothers. (NIV) 7. Love for everyone. 2 Peter 1:5-7 Supplement your faith with a generous provision of moral excellence, and moral excellence with knowledge, 6 and knowledge with self-control, and self-control with patient endurance, and patient endurance with godliness, 7 and godliness with brotherly affection, and brotherly affection with love for everyone. (NLT) 1 Corinthians 13:13 Three things will last forever—faith, hope, and love—and the greatest of these is love. (NLT) 1 Corinthians 13:4-8 Love is patient, love is kind. It does not envy, it does not boast, it is not proud. 5 It does not dishonor others, it is not self-seeking, it is not easily angered, it keeps no record of wrongs. 6 Love does not delight in evil but rejoices with the truth. 7 It always protects, always trusts, always hopes, always perseveres. 8 Love never fails. (NIV) 1 John 3:16 This is how we know what love is: Jesus Christ laid down his life for us. And we ought to lay down our lives for our brothers and sisters. (NIV) 2 Peter 1:8 For IF you possess these qualities in increasing measure, they will keep you from being ineffective and unproductive in your knowledge of our Lord Jesus Christ. (NIV) 2 Peter 1:8 The more you grow like this, the more productive and useful you will be in your knowledge of our Lord Jesus Christ.  (NLT)

America Out Loud PULSE with Dr. Randall Bock – Her experience reflects a broader pattern in modern medicine. Visits have expanded in scope while narrowing in purpose. Screening and risk inventories dominate encounters. Case-finding replaces diagnosis. Patients are evaluated for many things they did not come in for, while the problem that brought them there remains untouched...

I know 2026 feels like it ihas been here for months, but only a few weeks ago we were celebrating the nephrology accomplishments of 2025. The New Filtrate came together to review the year.The FiltrateJoel Topf‍ ‍@kidneyboy.bsky.social‬ (COI)Swapnil Hiremath @hswapnil.medsky.social and on LinkedIn Editor in Chief of Kidney International Case ReportsAnna Gaddy (@AnnaGaddy) Winner of NephJC Rookie of the Year 2020Nayan Arora (@CaptainChloride.bsky.social)AC (@medpeedskidneys.bsky.social)Vipin Verghese (@vipvargh.bsky.social) co-winner of NephJC Engaged Scientist of the Year in 2021Brian Rifkin (@brianrifkin.bsky.social) Co-Editor in Chief NephJC. Winner of NephJC Rookie of the Year 2021Cristina Popa (@NephroSeeker) Co-Editor in Chief NephJC. Wwinner of NephJC Rookie of the Year 2022 and MVP 2023Editing and Show Notes byAnna Gaddy and Joel TopfThe Kidney Connection written and performed by Tim YauShow NotesTop Stories in Nephrology 2025 (NephJC)First Top sories in Nephrology 2010! (Renal Fellow Network)Links to all of the Top Stories in Nephrology, hosted on NephJC since 2017 (NephJC)1. IgA NephropathyVISIONARY: Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial (NEJM)ORIGIN 3: A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy (NEJM)APPLAUSE-IgA Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy (NEJM)Aliza M. Thompson, MD, MS (ASN) 2. Lupus NephritisREGENCY: Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis (NEJM)3. Nobel prize winner and peripheral immune tolerance4. Xenotransplantation5. GLP1ra RevolutionRemodel REMODELing mechanistic trials for kidney disease: a multimodal, tissue-centered approach to understand the renal mechanism of action of semaglutide (Kidney International)SURPASS-CVOT Tirzepatide vs. Dulaglutide Is Associated with Reduced Major Kidney Events in Patients with Type 2 Diabetes, CVD, and Very High-Risk Kidney Diseases (Kidney Week abstract in JASN)Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford (KFF survey)6. GDMT implementation in CKD: lessons learnt from CONFIDENCE and MIRO-CKDConfidence Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (NEJM)MIRO-CKD Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial (The Lancet)7. Flozin Meta analysisSMART-C. SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria. A Meta-Analysis (JAMA)SMART-C. Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria. A Meta-Analysis (JAMA)8. Paradigm Shift: Aiming for CKD Remission9. Fish Oil and DialysisPISCES Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis (NEJM)10. Decline in Dialysis Patients in the United StatesUSRD 2025 Annual Data Report (USRDS)Tubular SecretionSwapnil Hiremath Alien Earth on FX Hulu (Wikipedia)AC A Christmas Carol by Charles Dickens (Wikipedia) and The Muppet Christmas Carol (Wikipedia)Anna Monty Don (Wikipedia)Nayan Back Street Boys at The Sphere (Wikipedia)Brian Marty Supreme (Wikipedia)Cristina The Yellow Tie (Wikipedia)Vipin Stranger Things, good for a four year old? (Wikipedia)Joel Crash Course: The Universe with Katie Mack and John Green (Apple PodCasts)

Welcome to Hacking Your ADHD. I'm your host, William Curb. Today, I'm joined by Skye Waterson for our research recap series, where we dive into a single research paper to find practical takeaways. In this episode, we're discussing a paper called "Adherence, Persistence and Medication Discontinuation in Patients with Attention Deficit Hyperactivity Disorder: A Systematic Literature Review." This study asks: what's happening in the real world with medication adherence? Are people taking their meds, and if not, why? I found this paper through a presentation by Bill Dobson at the 2025 ADHD conference in Kansas City, and it really blew me away. If you'd life to follow along on the show notes page you can find that at https://HackingYourADHD.com/268 https://tinyurl.com/56rvt9fr - Unconventional Organisation Affiliate link https://tinyurl.com/y835cnrk - YouTube https://www.patreon.com/HackingYourADHD - Patreon

Dr. Tesha Monteith and Dr. Michael Eller discuss the implications of CGRP therapies in migraine treatment, particularly for patients with vascular risk factors or a history of stroke.  Show citation: Eller MT, Schwarzová K, Gufler L, et al. CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke: A Review. Neurology. 2025;105(2):e213852. doi:10.1212/WNL.0000000000213852  Show transcript:  Dr. Tesha Monteith: Hi, this is Tesha Monteith with the Neurology Minute. I've just been speaking with Michael Eller from the Department of Neurology Medical University of Innsbruck, Austria on the neurology podcast on his paper, CGRP Targeted Migraine Therapies in Patients with Vascular Risk Factors or Stroke: A Review. Hi, Michael. Dr. Michael Eller: Hello. Dr. Tesha Monteith: Why don't you summarize your general approach to use of CGRP targeted therapies in patients that might be at risk for vascular events when considering safety? Dr. Michael Eller: Yeah. About acute vascular events, we should stop CGLP targeted drugs immediately. When we come to post-stroke, we should reassess the necessity of these targeted treatments after recovery. We suggest a minimum of three months pause after ischemic stroke to allow early recovery and remodeling, and then restart only after individualized benefit risk review. In high-risk primary prevention, so no stroke yet, but elevated risk, if the patients are 65 years or older with established cardiovascular disease, we should prefer traditional preventives. And if CGLP targeted therapy is essential, we should consider Gepants cautiously due to their shorter half lives. We should avoid CGLP targeted treatments in small vessel disease, distal stenosis, Raynaud's phenomenon, and uncontrolled hypertension. For acute migraine treatment, we can consider gepants or ditans as alternatives to triptans and NSAIDs in relevant stroke risk or post-stroke patients, individualized to comorbidities. Dr. Tesha Monteith: Great. And we should say that the label updates include hypertension and Raynaud's phenomenon as potential vascular complications. Otherwise, these are more theoretical risks based on what we know about CGRP. Dr. Michael Eller: Yes, I totally agree because large studies did not show any elevated cardiovascular risk signals. And for post-marketing databases, we did not see any elevated cardiovascular risk so far. However, in pre-clinical settings, studies showed large infarct size in pretreated mice. Dr. Tesha Monteith: Great. Well, thank you again for doing this work. It was a phenomenal read and congratulations. Dr. Michael Eller: Thank you. Dr. Tesha Monteith: This is Tesha Monteith. Thank you for listening to the Neurology Minute.

In this episode of American Potential, host David From talks with Sarah Scott about the remarkable story of Michael Yakubovich and the successful push to pass Right to Try legislation in New Hampshire. A former state representative, Michael was diagnosed with a terminal illness and quickly ran into the harsh reality many patients face: limited treatment options and government barriers standing between them and potential hope. Rather than accept those limits, Michael turned his personal fight into a cause. After being forced to travel to other states in search of experimental treatments, he worked with lawmakers to expand Right to Try so patients in New Hampshire could access innovative care without unnecessary red tape. His advocacy helped ensure that others facing life-threatening illnesses wouldn't have to leave their home state just to pursue a chance at treatment.

Kiera is joined by Dr. Paul Etchison to talk about changing the mindset of turnover = failure. This transition is part of the evolution of leadership. Both Kiera and Dr. Etchison share their own experiences in remaining true to core values, and keeping their definitions of success separate from whether a team member stuck around or not. Episode resources: Subscribe to The Dental A-Team podcast Schedule a Practice Assessment Leave us a review Transcript: Kiera Dent (00:00) Hello, Dental A Team listeners. This is Kiera and today is an extra special day. I have one of my faves and every time we podcast, people say, you two just seem like you love each other so much. And I really do. I've been to this man's practice. We've been friends in the industry for I don't even know how many years pre-COVID. That's a long time. And we've been on each other's podcasts a lot. He has an incredible podcast. He's an incredible human, incredible friend, incredible mentor. I got the one and only Paul Etchison on the podcast today. Welcome. How are you today, Paul?   Paul Etchison (00:28) Hey, I'm good. And I was just thinking about how you mentioned like the pre-COVID thing. You texted me a picture of when you came into my practice for two days. And it was like before COVID. And what was funny about it, and I don't know if it's funny or not, but like I looked at it and half of my team has turned over. They're all new people. So I know. ⁓   Kiera Dent (00:36) cute.   Mm-hmm.   It's real life, Paul. That's real life. It is funny and isn't because I go back and I used to   be embarrassed about that. So let's just kind of highlight on that. I used to actually be very embarrassed of like, my gosh, I don't have senior team members. And like, I hate the question. There was a hot minute. The Dental A Team felt like I was Johnny Depp in the middle of the ocean and my boat was full blown on fire. And I was like, I just hope another one shows up soon. Like I hope something comes. ⁓   And then I realized that's business ownership. Like that's real life. And yes, we built these great cultures, but you outgrow team members and team members outgrow you in life circumstances. And I'd rather be honest and real rather than perfect. And so the fact that like teams shift in a lot, mean, shoot, I used to have this vision board, Paul, you want to hear how ridiculous this was? And I took the team and I put them in the one year, the three year, the 10, and I just had this like same team follow with me. That lasted me for like six months. And I was like, rip this thing up.   Paul Etchison (01:31) Yes.   You   Kiera Dent (01:40) It's   gotten better, it's stabilized, but I think that that's real life. So thanks for talking about it.   Paul Etchison (01:44) It's hard,   yeah, I mean, we look at it and I think like the beginning of my practice career, I had very little turnover, but it was, I had to put so much into keeping that. Like it was such a hard thing to keep going. there was a lot of team members that I kept and I was able to make them happy and I was able to have it be a productive relationship and they were good at the practice. But sometimes I look back on it I'm like, man, it was just, that was a lot of energy I put into one person. I should have just moved on.   So that's how I practice now. It's different. There's a little bit more turnover and I think that's normal and that's part of business ownership. So we're okay.   Kiera Dent (02:16) What changed in your mindset for that? I have so many questions for you today. You guys, Paul and I, when we get on the podcast, it really is just like a free for all. And Paul has no clue. I have a full plan of what I'm asking you today, ⁓ but it's going to be a free for all rift of business ownership of teams. How did you change that perspective? Because I think so many people chalk that up to, I'm a failure of a boss if I've got turnover. Like I had a doctor the other day on a coaching call and she's like, Kiera,   Paul Etchison (02:19) Yeah.   Kiera Dent (02:42) What am I going to do for PR? Like I've got people turning over and how do I PR this? So anything is twofold. One, how did you get like mentally change that mindset? Cause I think it's a big mental game.   Paul Etchison (02:54) Yeah, for me, was everything that I've done in my career as far as like leadership growth and stuff, I think has always stemmed from some period of just struggle and burnout to some extent. It was like, I got to the point where I was taking everything that happened at the practice personally, every upset person at upset employees, they're bothered about something. They're they always, I mean, they're telling you how you should be doing things that not realizing that there's very complicated solutions. And sometimes there's not perfect solutions. A lot of times there's   perfect solutions. So I think what changed for me is I started looking at it from a point of my mental sanity saying I can't attribute my feelings on the happiness of all these team members anymore.   And all I need to do is just be very clear on what I want, be very consistent with the way that I treat them and hold them to that standard. But ultimately, I'm putting the ball in their court. It's up to them. And if they want to play ball, cool. If they don't, that's cool too. We can still be friends and you can go to some other office where it's more to your liking. But the biggest change for me was just realizing I can't be everything to everybody. And I did it for a long time and it was really exhausting. And I worked through that and I feel a lot better   it.   I think my team   is better for it.   Kiera Dent (04:08) Yeah, no, I don't disagree. And I'm glad you talked about that. It's been fun. think Paul, you felt like, I don't know, a big brother to me when we met and I came out to your practice and the fun things we've been able to do together and just the differences. ⁓ I think as we've grown up in the industry together, but I, I admired that because I always thought you had this amazing team. And I think to hear your version and then my version at the same time was very similar. I just realized like,   We got a killer team. Like this is an amazing company. And I think when I evolved to you're so lucky to work here, you're so like not in an egotistical way, but I think in a confidence way of like, this is a great place and we're going to attract people. I started realizing like I had confidence to make offers of what we actually wanted to pay versus what I felt like I had to chase to get people to be here. ⁓ we pivoted and I used to like chase all the time and try to be everything for everybody. And then I'm like,   Why am I doing this? Kiera, like you have built a company and a culture and a space that people love. And yes, there are changes and I will continue on forever evolve. I don't think that we're a perfectly set company, but I think that we're a pretty great, awesome place to work. And I think when I became centered, confident in me and what I was providing in the culture without having to be everything, I noticed I actually attracted a way different type of employee. I attracted somebody who wanted that same style. They, it,   It was like no more like games. think in like compensation and all this, it was more just centered. It was like, this is what we do and this is who we are and I want great people. And I also think it was very much attributed to like, got dialed in on core values. And I was like, I'm sticking to these. These are like rock solid. do not deviate from that. And if you don't fit. Fantastic. There is another opportunity, like go find your dream place and we're going to find our dream team member. And I say that in a very like confident, hopefully not egotistical. And I think you, sounds like you did a similar thing, but I.   I will say, I think you go through a space of realizing you're not a failure. It's an evolution. I think of, of leadership. It's almost like going from, I don't want to say immature. It's more like children and how's they grow. Like, I don't think a little baby is a failure for having that knowledge and that mindset. And I think some of us, are toddler baby owners. Like we've never done this before. We don't know. So we're going to have a different mindset. And then you just start to morph and evolve just like   Children grow up and they morph and evolve into these teenagers, into these college students, into like the prime of their life. To me, that also feels like a maturity of leadership as well to being confident with that.   Paul Etchison (06:42) Yeah,   I love that you point that out too, because we do, we hear a lot of complaints from our team members and then we start to, it starts to add up and then we start to really doubt.   Did we really create a great work environment? I mean, we just had an all day meeting maybe about two months ago, maybe six weeks ago,   like that. And one of the questions I asked, we use this thing called Slido. It's just in real time, you put on a PowerPoint slide and everybody can vote on their phone. There's a million like programs that do this. But I asked the whole team anonymously on a scale of one to 10, how fun is it to work at Nelson Ridge Family Dental? And I was terrified to throw that   Kiera Dent (07:03) Thank   Paul Etchison (07:19) there. I had no idea what people were going to say.   Kiera Dent (07:20) I don't blame you.   Paul Etchison (07:22) It was everybody was like eight, nine. There was like three or four sixes. Now I have 30 something team members.   So the   Kiera Dent (07:29) Yeah.   Paul Etchison (07:30) of it was very good, but it was, it was scary.   if you would have asked me what I thought it was going to   Kiera Dent (07:35) Mm-hmm. Mm-hmm.   Paul Etchison (07:37) I did not think it was going to be that good because the squeaky wheel gets the grease. This, you know, that's what we hear. That's what we focus on. And it reminds me of this one coaching client I had, cause I coached dentists as well. had a coach coaching client named Isaac and he did very similar to you.   choir practice, he really got deep into the foundational core values of this is what the practice is. And   turned over his entire team and he said, I feel like such a failure. I feel like everybody's leaving. I feel like I'm just turning everybody off. Patients are coming in and asking where everybody is. I just don't think my leadership's good. And I told him, just hang through,   Hang, you'll find your people. And then six months later, he was like, I cannot tell you how much I love my team. And so I think the message of what you and I are saying, Kiera, is that no matter   Kiera Dent (08:12) Mm-hmm. Mm-hmm.   Right.   Paul Etchison (08:22) what you want to do with what kind of vision you have for your practice, your team's out there. They are there. They are waiting for someone to take charge and just make it a big deal that that's the type of people we have at this practice.   Kiera Dent (08:26) Mm-hmm.   Paul Etchison (08:33) So if anyone's listening thinking like, have this issue at my office, get those core values out, talk to the team about it. Don't just like leave it on a document, bring it up with ⁓ a meeting and say, guys, this is what I truly want.   And sometimes apologize. I'm   I haven't been holding everyone to the highest regard or the highest standard, but I'm ready to do it and I need your help. So I love that you brought up those two points. Those are amazing things and I think everybody struggles with that.   Kiera Dent (08:55) Yeah.   I think, and I think that that's something that I feel you and I both strive to do is tell people feel like they're not alone. I think so many doctors feel like I'm the only one out there. I'm the only one who can't keep my team there. I'm the only one who has team turnover. And like, this is not the path that we were even on my radar to head, but I think it's obviously the most important path for people to hear. ⁓ I think Paul, it's the no judgment. It's the hang through it. It's, ⁓ having a guide, a mentor who's been there, done that, done that successfully. I mean, you and I can both like,   Gosh, you like grit through that and it's painful. But I also believe that while yes, painful, I feel it's an evolution of soul that you actually internally are craving. I don't believe that we rise to the call until we're ready. Like Kieran 2020, when I'm sitting on Johnny Depp like boat in the ocean, it was on fire. I was not ready for the call and the evolution that came in 2024 for me.   Like I just, wasn't ready for it, but come 2024. And I think it's a, it's a shedding, it's a shifting. It's a, like, I call it like the skin sloughing. Like it's like a snake, like you're leaving it behind. It's, I watched penguins when I was in Antarctica, like small flex there, Paul. Like the Antarctica trip was pretty rad. And we watched it. Right? We went to Antarctica. Penguins are so cute and they smell terrible. Like they're like little ketchup bottles that just squirt poop all day long. And it's disgusting.   Paul Etchison (10:11) I was just going to follow up on that. Whoa.   Kiera Dent (10:25) but they were molting when we were there and they just looked absolutely miserable. Like they sat there and they told us like, please don't touch the penguins. like, these look just, they're like, it's very painful for them. They're having to completely molt off all of these feathers. And I think that that's how I feel a lot of business owners are like, are you going through that molting process? But again, just like those penguins, just like us, I really do believe that when we're ready to be called to that higher level, one, you're not alone, two, you don't have to go through it alone.   Three, it's normal and it's part of growth, but like, there's also, you don't have to grow until you actually want to. Like, it sounds like Isaac was just ready. Like, I'm ready, I'm done. Like, I've hit my limit. I was ready, I was done. I was like, we are having a complete culture shift. Like, we're done and like, it needs to evolve. Sounds like you had it. But I also feel, and I don't know how you feel, Kieran 2020, Kieran 2024, even into 2025, leadership culture company.   keeps evolving. don't feel like I have as many of those like huge molting in 2020, huge molting in 2024, 2025. It's more of a shift in a refinement rather than a full molt. But that's, think how, at least for me, that's how I think I view leadership is.   Paul Etchison (11:37) Yeah, totally agree. It's like we go through these stages of leadership growth. And I remember for me, like leadership all the way up to COVID was like system, system, systems, consistency with team. And my team grew to like 35, 40 people and it got really unmanageable. And then when we came back from COVID from being shut down, I really wanted to try to do something different. And I wanted to keep that. ⁓   I just loved when we were shut down for COVID. I loved how it felt. It felt easy. And I said, I want that, but I don't want that craziness when we open up again. And when I did, I started to feel that same craziness. And I was going to therapy at the time. And like the therapist will tell you, just change your expectations. Don't take everything personally. And what I learned through that is there's no amount of therapy that can   broken leadership   Is that I had systems, I had consistency, but my team   had outgrown those systems. We needed more systems of leadership. So the next stage in my leadership was learning how to lead leaders and truly delegate and truly give them the autonomy to do everything. And when we did that, everything got so much better. there was parts of me that was like, I'm not the right person for this level of organization. not the right person for this size of a dental office. I'm just too anxious. I take   Kiera Dent (12:41) Mm-hmm.   Paul Etchison (12:59) too personally. And ultimately, I think it was just I   Kiera Dent (12:59) you   Paul Etchison (13:02) set up, I didn't set up my organization the proper way. So that was the next level up for me. And I think that's me shedding my skin finally once and for all to learn how to lead leaders. And who knows what's   Kiera Dent (13:14) Paul, I think that you are actually a really good example of letting go of control. How do you do that? Like,   I remember talking to you one day, this is offline, hopefully I'm not oversharing. And you're like, a lot of people say, like, what are you going to do if you retire? And I know you sold your practice to a DSO and you're like, I've never looked back. Like it was great. Um, you're like, I'm actually the person who's okay to just like sleep in and do nothing. Like I really am okay with that. Like, how did you let go of that control with your team? Um, knowing that they weren't going to do it exactly like you, like, I think people have this in theory. They try to do it, but.   Paul Etchison (13:23) No, of course not.   Kiera Dent (13:49) Like that's another molting. That's another really hard gap to go from full control. You're in charge of everything to I'm stressed out. Now I'm going to let team members take over and maybe you're, maybe you're an anomaly, maybe you're a unicorn, but how did you do it?   Paul Etchison (13:59) Yeah.   I think it's like we talked about the growth, but I think where we screw up as practice owners when we do this is we get upset that the team members are not doing exactly the way that we would do it. And there needs to be some wiggle room. There needs to be a lot of forgiveness. But ultimately, there's got to be clarity. And not enough practice owners are having the conversations with their team members. Like I always say, like, I'm coaching dentists all the time, and they're telling me about these issues they're having at their practice. And I'm saying, well, why do you think that is? And the answer is like, well, it might be this.   kind of think it's this and it's like, well, get curious, ask, ask your team. So for me, it was about telling my team what's expected and when   Kiera Dent (14:36) Mm-hmm.   Paul Etchison (14:42) didn't meet expectations, instead of like dancing around it, just going right at the   getting curious, what is going on with this? What is, why is this not happening? And then always like, you know, if you ask the right questions, the next step for any leadership, any leader is to validate their perspective.   no matter what it is and that will go so far. If you take one thing out of this podcast, do that. When your team members share something with you or if you're getting curious, asking them why things are happening, how they're feeling about something, validate their experience and watch how much they open up and they're.   open to behavior change and other options. And then that allows you the opportunity to then ask and invite participation in the solutions. What do you think we should do?   I noticed our cancellations are getting up there. Like, what are we doing about this?   What do you see happening? Getting curious. And they're saying, well, I don't know. Like, I got to ask some more   OK. And then validate their experience. I totally see how maybe you got busy with your other things and you haven't been asking your team. But we've got to ask the team and find out just so many little things.   For me, was getting out of the way, being clear with expectations. But then instead of trying to go around my leads and my leaders, my practice and go around them and deal with the other other teams myself, I let them do it and I let them fail and I help them and I support them.   And I think I know there's a lot of like team members that listen to your podcast, Kiera. I would hope if you're listening to this and you're team member, I would hope you understand how valuable you are to an owner. If you can take things, find solutions and hold your, your team members, your fellow coworkers to a certain standard, like you would be so valuable. Everyone's like, well, how can I get a raise? How can I contribute more value? I would people on my team, my leaders that do this for me, they are so valuable to me and every owner.   is just waiting for somebody to step in and fill that role. I mean, every practice could use   Kiera Dent (16:38) team members, their number one objective is to make their doctor happy.   every day, all day. That's like what my job is. That's what I want to do. That's how I want to serve. That's how I want to help out. ⁓ And I think as owners, I think it can be easy to see all the problems in your team. But I think it's what pair of sunglasses do I want to put on? Do I want to put on the one where I see like, what's wrong is just as available as what's right. Both are always available in every single scenario, every single situation. And so what are we bringing to the table and how are we looking at these different things?   How are we guiding our teams? How are we guiding our leaders? How are we showing up as leaders? How are we like, what is the filter I'm putting on every single day? Like those, those two sunglasses are right there as you walk out the door and which pair are you choosing to put on? Cause you're going to influence impact and create a team. No matter what we see what we want to see. And I believe that we create our own realities. I believe that reality is what we believe it is. And so, ⁓ I think shifting that seeing that, and I think having just a bigger plan, a bigger vision. know when I got very crystal clear of where am I headed?   What is my role? Like, this is gonna sound funny, Paul. I literally Googled like, what does a CEO do? I think doctors come out of school, like you're a doctor, like you do the dentistry, like that's what I'm supposed to do. And I remember one day I was sitting there and I'm like, what is the CEO even supposed to do? Like, I don't even know, like, like really, like where is a CEO, like dictionary, like job description, I realized, got it. It's profit, vision, and culture. Like those are really my main things. Stay out of the weeds and like go for it. And...   Paul Etchison (17:43) you   Kiera Dent (18:04) That's what I'm bred to do. Bring the great ideas, bring those different pieces. That's my job. That's my responsibility. I think dentists also have the second tier of you do dentistry too. So you are a clinician in there and then you have those pieces. But driving culture, driving a culture of accountability of fail, fail forward. like, gosh, I just read this really awesome book and they said, we measure it by outcomes, not activity.   Like just stuff like that. Like you start to become this person who wants to evolve your culture, evolve who your team is, evolve who you are as a person. And I think Paul, even in just knowing you, I think there's been an evolution of who you are as well. ⁓ I think that is just, and hopefully I've evolved too, like fingers crossed there's been an evolution and I'm not as quite, I don't know. I think we keep the best of ourselves. And then I think just evolve into our 2.0, 3.0, 4.0 levels. I guess I just asked the questions of   Paul Etchison (18:42) Absolutely.   Kiera Dent (18:58) I think you've got a fascinating story. You were full, full practice owner. You were in there. You sold out to a DSO. You're still in your practice. You still train. You, you've evolved. If you were sitting back when I met you, what would you tell that Paul of what you know today that would have made that whole experience, whether you're selling, whether you're growing, evolving. I mean, you have a very large practice. It's been real fun to watch you and your practice and everything. What would you have told that Paul?   Paul Etchison (19:27) Yeah, and this comes up a lot with my coaching clients. A lot of people ask me that. And one of the things, if we're looking at our practice, and I'm going back to the beginning, is if we want to sell our practice, if we want to cut back our days, if we want to have the most profitable practice ever, a lot of the times the strategy is identical. We're just trying to go through and create more freedom for ourselves as practice owners by empowering our team, getting them to do a lot of the responsibility.   Kiera Dent (19:48) Mm-hmm.   Paul Etchison (19:57) to be accountable for a lot of the stuff. So I think if I could go back and tell myself again, man, first of all, just stop taking everything so personal. And you come in and you look at it with these different lens of leadership and maturity and all these leadership skills. It's not just at the practice. It shows up in your relationships with your spouse, with your friends, with your kids, like all these things. Like it's all intertwined. But I would have much earlier got the leaders going in my practice because one of the things   Kiera Dent (20:16) Mm-hmm. Mm-hmm.   Paul Etchison (20:27) happen through my practice sale is I just like I mentioned I felt like it wasn't I'm not cut out for this I'm sick of being miserable I'm sick of being stressed I'm sick of taking it home and I'm sick of taking it out on people that I love and so when I sold it I said okay I'm on my three-year exit plan I'm getting out of here I'm moving on I don't know what I'm gonna do but I'm gonna move on so I said you know my associate partner Dr. Kathy she owns part of the practice too   I'm gonna pass it to her and maybe she won't be able to do it as well as me. But I need to set this up so she is just, I wanna bless her with this amazing practice that runs on its own. And in the process of setting that up with my leaders, I realized, dang, I don't know if I would have sold. And I'm still happy I sold, don't get me wrong. I'm not saying I would have, but that's what I would have tried to do early in my career. I would have went, who are the leaders? ⁓ The whole thing with like the Dan Kennedy of the who, not how. Not how do we do it, but who's gonna do this?   Kiera Dent (21:11) Mm-hmm, mm-hmm, mm-hmm.   Right.   Paul Etchison (21:25) And I would have leaned into that a lot more because I think I would have been a lot happier. I would have been able to enjoy the journey more. But at the same time, it's like we learn from our mistakes and you got to make the mistakes to learn from. So it's like, so that whole Catch-22, would I change anything? I don't think so because I wouldn't be, if I didn't have the same experience, I wouldn't be the person I am today. But man, I wish I had learned it earlier. That's for sure.   Kiera Dent (21:45) Sure.   It's fair. And I'm actually happy to hear that because I feel like this is like the DSO conundrum and like the cell. And I'm happy to hear you say that because it validates what we try to coach on to. So many doctors are like, I'm just going to sell. And I'm like, well, let's just look at this. If you sell, let's look at what your life will look like on the other side of it. Let's look to see where you are today. And really, let's get to the root of why do you want to sell? And I think, Paula, if we would have asked you that same question.   Why did you wanna sell? My hunch is it was all these problems, all these issues. It was just like, I'm sick of it. Like, let's just pass this on. Let's move on. When a great leader, a great office manager, a CEO, a CFO could have easily come in, taken over for you. You could have had the exact same scenario. You just would have owned it and had more options on the table. Like you said, it's not right, it's not wrong. But I think like for everybody listening, I think today is a good reflection of one, are you going through a molt? Like, are we molting anywhere?   ⁓ and do we, or do we need to molt? Like, is there something we need to shed, let go of identity wise? And then two, I like to do this reflection a lot. And I encourage a lot of people to do it. It sounds like Paul, you do it. Like when we're in these issues in these problems, are we stopping and pausing and asking like, what is the root? Not the symptom, the top line symptom is like, I'm so stressed. And I got this and this and this, but like, do we ever stop and pause to dig to that route and find out   what is really at the root. For me, I often have many journals that are like this, this, this, and I just like list it all out of all these things are frustrating me. But what I'm trying to do is find what is a thread? What is the piece in that that's causing the chaos because then we go fix that. And that's what I love in practices because 99 % of the time what people tell you on the top line, so coaching offices, coaching doctors, coaching teams, like Paul, you know this, I know this. What people tell you at the top is not really what's the problem.   It's the bottom layered, there's something rooted, there's something under there. These are just symptoms on the top. Same thing with patients and case acceptance, right? It's the up at the top, what they're telling you is not really what they're feeling. And all you gotta do is just dig under, find out what that root is and stress and that will go away. And so Paul, thank you for, I just am curious. I've always been curious, like, would you have done something differently? Of course we never can, like, no, we're not going to. But if I could go back and tell that younger self things, like,   Kyri, get rid of your ego, honey. Like trust your team, trust that team to do amazing, trust them to do better than you are, trust them to be better than you, trust them to make better decisions than you do, because I want to create that kind of a team and me believing that is going to ultimately turn my team into that. They have the whole study about teachers with kids and IQs and like if they believe that they have a stronger IQ without doing anything different, that child actually ends up with a higher IQ. Well, why don't we take that same principle and apply it to our teams and see what happens.   Paul Etchison (24:23) Yeah.   It's so true. And I love that you say like the reflection that you did, because I noticed this with my coaching   is that there's a lot of, there's a lot of how, how do we do this? How do we fix this? But I think anyone listening, if you just sat down in a dark room, maybe not dark room, but you're sitting down in a quiet room for 30 minutes and you reflect it, what do I really, you know, I do this with my coaching clients. We call it a practice clarity and frustration exercise. What do we, what really bothers you with the practice? What is it that really just, you know, grind your gears,   it down and it sounds simple but once you write it down you can like visually see it and start to brainstorm for solutions and you start to make this progress that not only affects the way your practice runs but the way that you're the way that you feel and I think ultimately as practice owners we need to realize that the CEO hat you mentioned what does a CEO do we need time for that and we don't have time for that when you're doing four or five days of dentistry that's why when I'm working with clients the first thing I'm gonna do with a practice owner is I'm gonna get them down to three days clinic   Kiera Dent (25:10) Mm-hmm.   Paul Etchison (25:27) And it always works. so inefficient. There's so many things we can do with scheduling and efficiency and production that we can get you down to three days clinical. But now you've got that extra day to put on that CEO hat, to reflect on the things, to write down and figure out what your plan of attack is. I mean, that's what I've got a workshop coming up in February that that's focused on that. How do we get you down to three days? And that's all I want to do in this three day workshop. We're, of course, doing these reflection activities. But I think this is over the course of my career and working   Kiera Dent (25:27) Mm-hmm.   Paul Etchison (25:57) with people, that's what I've seen moves the needle the most. We need time and we need to give the energy where it's due. And it's not, we   be 100 % clinician. It just doesn't work that way.   Kiera Dent (26:09) Yeah, no, Paul, I love that. And think that's such a fun thing. I think dentists need this. Dentists need to have their vision, have their clarity. But I think from today, the wrap is it started out with a photo, unexpectedly, of this is what we're ⁓ kicking the day off of, going from where we were to where we want to be, ⁓ looking at that, reflecting back, seeing. Because   Paul Etchison (26:23) Yeah. How do we get here?   Kiera Dent (26:34) There's a client that you and I both know. They're pretty well known ⁓ that we work with. whenever I work with, gosh, it's so many practices. I think there's like 300 employees and I'm like, gosh, I remember all their names every time. ⁓ But they talk about how sometimes the best learning is just remembering. Remembering where we've been, remembering where we're going to go, remembering things that we've learned looking there. So it's like remembering where I've been so that way I can kickstart and project into where I need to go.   using your team to get there. Your team wants to be your best asset for that. So Paul, those are kind of my wrap thoughts. I know today has just been a real fun day. Always enjoy a good podcast with you. Any last thoughts you have?   Paul Etchison (27:15) No, you know, I would just close it off with   having the listener just believe, just believe in the possibility of what's going, what is possible with your practice. ⁓ There was a point where we talked about reflection. I reflected and I said, I wrote down everything I do at the practice and I wrote down how many of these activities bring me joy and how many of them I hate. And I believe it was something like 80 % of them I hated. So that's no way to live your practice life. You spend a lot of time at work. So why not do the reflection and put the time and energy into   Kiera Dent (27:38) Mm-hmm.   Paul Etchison (27:45) Making your practice a better place to be at it's not just gonna affect you. It's gonna affect your family. It's gonna affect your team ⁓ There's big your ripples that come from this little thing So I would say sit down find a coach find a mentor read some books it is possible believe in yourself and It all starts with the planning so sit down and write down some things journal love it   Kiera Dent (28:09) Journal it up. Well, Paul, I appreciate you so much.   I ⁓ just love what you're doing for our community. I love the things that we're able to accomplish together. ⁓ And yeah, guys, check him out in Dental Practice Heroes podcast. He's got some great stuff over there as well. ⁓ Paul, so good to have you on the podcast. I think you mentioned the event in February. If people want to know more about that, how do they connect with you on that?   Paul Etchison (28:35) Yeah, go to DentalPracticeHeroes.com slash freedom. So that's where the information on the three day workshop, it's going to   awesome. And I'm doing a money back guarantee. If you don't think you liked it, if you don't like what you signed up for, I'll give you all your money back. I believe in it that much. And I know from me coaching for the past six years, I know this is what produces results. So go check that out,   more about the courses, check out the podcast. And I'm always happy to talk to any listeners if they want some help or they just want to find out what we're more about. Please just go to the website, DentalPracticeHeroes.com.   dot com.   Kiera Dent (29:06) Amazing. Paul, thank you so much for being on the podcast. For all of you listening, I hope you do take the time to reflect. I do hope you think about where you want to go and what you want with your life. And just appreciate you guys all being here. And as always, thanks for listening. I'll catch you next time on the Dental A Team Podcast.  

Dr. Gabrielle Lyon is a board-certified physician, New York Times bestselling author, and the founder of the Forever Strong movement. With a background in nutritional sciences and geriatrics from Washington University, Gabrielle has spent years studying how protein and muscle impact aging, performance, and disease prevention. When it comes to longevity, muscle is the key. And now, Gabrielle is on a mission to make that knowledge accessible for you. Through her clinical work, books, top-ranked podcast, talks, and work with Special Operations Forces, Gabrielle translates cutting-edge research into practical strategies that actually work. Socials: Website: https://drgabriellelyon.com/ Youtube: https://www.youtube.com/DrGabrielleLyon X: https://x.com/drgabriellelyon Instagram: https://www.instagram.com/drgabriellelyon/ Facebook: https://www.facebook.com/doctorgabriellelyon/ Timestamps: 00:00 Trailer 00:30 Introduction 03:56 Impact of dietary guidelines on food 08:55 Muscle's role in health outcomes 13:10 Skeletal muscle risks of GLP1s 14:35 Patient education and drug risks 20:25 Muscle, myokines, and brain connection 24:00 Sprint training for longevity 26:41 Tendon strength and athletic longevity 29:48 Stress builds strength 34:51 Glutes: power, health, and longevity 36:09 Prioritizing protein for muscle health 39:41 Optimal protein intake for health 43:34 Challenging nutrition guidelines effectively 45:50 Balancing research and real-world nutrition 51:18 Future goals and challenges 53:22 Where to find Dr. Gabrielle Lyon Join Revero now to regain your health: https://revero.com/YT Revero.com is an online medical clinic for treating chronic diseases with this root-cause approach of nutrition therapy. You can get access to medical providers, personalized nutrition therapy, biomarker tracking, lab testing, ongoing clinical care, and daily coaching. You will also learn everything you need with educational videos, hundreds of recipes, and articles to make this easy for you. Join the Revero team (medical providers, etc): https://revero.com/jobs ‪#Revero #ReveroHealth #shawnbaker  #Carnivorediet #MeatHeals #AnimalBased #ZeroCarb #DietCoach  #FatAdapted #Carnivore #sugarfree Disclaimer: The content on this channel is not medical advice. Please consult your healthcare provider.

Show notes at pharmacyjoe.com/episode1100 In this episode, I'll discuss the safety of tenecteplase in patients with stroke mimics.

A daily preventive pill can be invaluable for people at risk for HIV. But some doctors don't know much about prescribing them and billing headaches are common. Here's how to overcome those obstacles.Have a question about navigating the health care system? Contact us here.Follow us on Instagram: @nprlifekitSign up for our newsletter here.Have an episode idea or feedback you want to share? Email us at lifekit@npr.orgSupport the show and listen to it sponsor-free by signing up for Life Kit+ at plus.npr.org/lifekitLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Dr. Tesha Monteith talks with Dr. Michael Eller about the implications of CGRP therapies in migraine treatment, particularly for patients with vascular risk factors or a history of stroke.  Read the related article in Neurology®. Disclosures can be found at Neurology.org. 

Links & Mentions: Consult booking link: www.dryazdancoaching.com/consult Email me: DrDYazdan@gmail.com Make more money video: www.dryazdancoaching.com/MDM Follow me for more tips: (@DrYazdan) www.instagram.com/dryazdan and (@DrYazdanCoaching) www.Instagram.com/dryazdancoaching Episode Summary: Inside this episode, we break down the unspoken power structures in the operatory, within your team, and in your patient relationships — and how to use this awareness to elevate your entire practice

In this episode of The Egg Whisperer Show, I'm diving into the ten things I tell my fertility patients to stop doing every single day in my practice. As a fertility specialist who's been working with patients for years, I've noticed certain patterns and behaviors that can make the fertility journey more stressful than it needs to be. Whether you're just starting fertility treatments, in the middle of IVF, or trying to conceive naturally, this episode is packed with practical, science-based advice that will help you navigate this process with less stress and more confidence. I'm sharing the real talk about everything from baby showers to coffee consumption, and yes, even the prescription for ejaculation that sounds silly coming from a doctor's mouth but is scientifically valid. Read the full show notes and transcript on Dr. Aimee's website Throughout this episode, I explore the physical, emotional, and lifestyle factors that impact fertility treatment success. I discuss why it's okay to set boundaries, how to optimize sperm health, what you really need to know about exercise during IVF, and why that cup of coffee you've been avoiding is actually perfectly fine. My goal is to help you feel empowered to make informed decisions, reduce unnecessary stress, and approach your fertility journey with a positive mental attitude. I want you to stop doing things that don't serve you and start focusing on what actually matters for your fertility success. In this episode, we cover: Why you should skip baby showers and learn to say no without guilt during fertility treatment The truth about alcohol consumption during fertility treatments and when moderation is okay Exercise guidelines before and after egg retrieval, and why listening to your body is crucial Why abstaining from sex during fertility treatment is actually counterproductive and how frequent ejaculation improves sperm quality The importance of keeping your fertility journey private and choosing your support circle carefully How to choose sperm-friendly lubricants and avoid products that harm fertility Why stress about stress is unnecessary and how to build your fertility support team The impact of heat exposure on male fertility and why "cooking your balls" is a real concern Why you don't need to give up coffee during fertility treatment and the science behind caffeine consumption The power of positive mental attitude (PMA) and stopping negative thinking patterns Do you have questions about IVF? Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, February 9, 2026, at 4 pm PST, where Dr. Aimee will explain IVF and Egg Freezing, and there will be time to ask her your questions live on Zoom. Other ways to follow Dr. Aimee: Visit my YouTube channel for more fertility tipsSubscribe to the newsletter to get updatesJoin The Egg Whisperer SchoolRequest a Consultation with Dr. Aimee  Dr. Aimee Eyvazzadeh is one of America's most well‑known fertility doctors. Her success rate at baby‑making gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org. Keywords: fertility treatment, IVF, egg retrieval, fertility tips, trying to conceive, sperm health, fertility stress, fertility doctor advice, egg whisperer, Dr. Aimee, fertility journey, IVF tips, male fertility, female fertility, fertility lifestyle, fertility boundaries, positive mental attitude, fertility support, fertility podcast, reproductive health, infertility, fertility wellness, TTC tips, fertility mindset, IVF preparation, fertility recovery

Can trimming overhead expenses open the door to lasting patient relationships and steady, meaningful growth in your practice?In this interview, Dr. Andy Brito shows us the secrets behind his steady growth at Brito Family Dental: a beloved, family-run practice serving South Boston. From day one, Dr. Brito prioritized low overhead and resource efficiency, opting for conservative treatment plans that build trust and keep patient costs accessible. His approach to dentistry goes beyond filling cavities; it's about forging relationships, earning loyalty, and upholding the highest standards through constant growth and learning. With over $200,000 invested in continuing education, he has continually raised the bar for clinical skills, bringing advanced procedures like full-arch surgeries and implants to his patients while keeping prices fair.Dr. Brito doesn't just rely on clinical excellence to set his practice apart. He shares the marketing strategies (successful and not-so-successful) that helped Brito Family Dental build its reputation, from tapping into his Portuguese heritage to connect with the local Brazilian community, to refining Google Ad targeting for quality patient leads. Bringing lab work in-house has slashed costs and enhanced service quality, reinforcing his commitment to efficiency without sacrificing care. For Dr. Brito, growth isn't about getting bigger; it's about staying agile, keeping a close-knit team, and heeding the lessons learned along the way.What You'll Learn in This Episode:How managing overhead can strengthen patient relationships and grow your practiceTips for maximizing the impact of continuing education in dentistryThe real-world impact of introducing an in-house dental labMarketing wins and misses: from targeted online ads to cultural community outreachWhy staying small and agile can outperform rapid expansionLessons on cost-saving without sacrificing qualitySmart ways to vet marketing investments early onKey advice for new and established dentists seeking sustainable growthHit play now to discover how Dr. Brito's practice continues to grow sustainably in a highly competitive scene!‍Sponsors:‍Net32: Founded by a dentist, for dentists. Net32 is the leading online marketplace for dental supplies, helping dental and medical professionals save on high-quality products for over 25 years. Start saving today at: https://www.net32.com/dentalmarketerGuest: Dr. Andy BritoPractice Name: Brito Family DentalCheck out Andy's Media:‍Website: https://britofamilydental.com/Email: andybrito3@gmail.com‍Host: Michael AriasJoin my newsletter: https://thedentalmarketer.lpages.co/newsletter/‍Join this podcast's Facebook Group: The Dental Marketer Society‍Love the Podcast? Let Us Know How We're Doing on Apple Podcasts!

Today we look at the story of Frank Olson, bacteriologist and CIA scientist involved in the early years of biological warfare research and the infamous MKUltra mind-control program. His 1953 death is one of the most persistent mysteries in American intelligence history and today we break down everything...WELCOME TO CAMP!